0000910406-21-000018 | 10-Q | XBRL Viewer

Print Document View Excel Document

RELATED PARTY TRANSACTIONS (Details) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
	Apr. 15, 2021	Mar. 31, 2021	Mar. 31, 2020	Mar. 31, 2021	Mar. 31, 2020
Dream WestSoy \| Subsequent Event
Related Party Transaction [Line Items]
Proceeds from divestiture	$ 33,000
Director
Related Party Transaction [Line Items]
Expenses from transactions with related party		$ 3,649	$ 2,513	$ 12,806	$ 13,106
Former Director
Related Party Transaction [Line Items]
Expenses from transactions with related party		$ 259	$ 1,141	$ 1,476	$ 3,629

DERIVATIVES AND HEDGING ACTIVITIES

9 Months Ended

Mar. 31, 2021

Derivative Instruments and Hedging Activities Disclosure [Abstract]

DERIVATIVES AND HEDGING ACTIVITIES

Risk Management Objective of Using Derivatives

The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company manages economic risks, including interest rate, liquidity and credit risk primarily by managing the amount, sources and duration of its assets and liabilities and the use of derivative financial instruments. Specifically, the Company enters into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future known and uncertain cash amounts, the value of which are determined by interest rates. The Company’s derivative financial instruments are used to manage differences in the amount, timing and duration of the Company’s known or expected cash receipts and its known or expected cash payments principally related to the Company’s receivables and borrowings.

Certain of the Company’s foreign operations expose the Company to fluctuations of foreign exchange rates. These fluctuations may impact the value of the Company’s cash receipts and payments in terms of the Company’s functional currency. The Company enters into derivative financial instruments to protect the value or fix the amount of certain assets and liabilities in terms of its functional currency, the U.S. dollar.

Accordingly, the Company uses derivative financial instruments to manage and mitigate such risks. The Company does not use derivatives for speculative or trading purposes.

Cash Flow Hedges of Interest Rate Risk

The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. During the three and nine months ended March 31, 2021, such derivatives were used to hedge the variable cash flows associated with existing variable rate debt.

For derivatives designated and that qualify as cash flow hedges of interest rate risk, the gain or loss on the derivative is recorded in AOCL and subsequently reclassified into interest expense in the same period during which the hedged transaction affects earnings. Amounts reported in AOCL related to derivatives will be reclassified to interest expense as interest payments are made on the Company’s variable rate debt. During the remaining three months of fiscal 2021, the Company estimates that an additional $174 will be reclassified as an increase to interest expense.

As of March 31, 2021, the Company had the following outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk:


Interest Rate Derivative	Number of Instruments	Notional Amount
Interest Rate Swap	4	$230,000

Cash Flow Hedges of Foreign Exchange Risk

The Company is exposed to fluctuations in various foreign currencies against its functional currency, the U.S. Dollar. The Company uses foreign currency derivatives including cross-currency swaps to manage its exposure to fluctuations in the USD-EUR exchange rates. Cross-currency swaps involve exchanging fixed-rate interest payments for fixed-rate interest receipts, both of which will occur at the USD-EUR forward exchange rates in effect upon entering into the instrument. The Company, at times, also uses forward contracts to manage its exposure to fluctuations in the GBP-EUR exchange rates. The Company designates these derivatives as cash flow hedges of foreign exchange risks.

For derivatives designated and that qualify as cash flow hedges of foreign exchange risk, the gain or loss on the derivative is recorded in AOCL and subsequently reclassified in the period(s) during which the hedged transaction affects earnings within the same income statement line item as the earnings effect of the hedged transaction. During the remaining three months of fiscal 2021, the Company estimates that an additional $82 relating to cross-currency swaps will be reclassified as an increase to interest income.

As of March 31, 2021, the Company had the following outstanding foreign currency derivatives that were used to hedge its foreign exchange risks:


Foreign Currency Derivative	Number of Instruments	Notional Sold	Notional Purchased
Cross-currency swap	1	€24,700	$26,775

Net Investment Hedges

The Company is exposed to fluctuations in foreign exchange rates on investments it holds in its European foreign entities and their exposure to the Euro. The Company uses fixed-to-fixed cross-currency swaps to hedge its exposure to changes in the foreign exchange rate on its foreign investment in Europe. Currency forward agreements involve fixing the USD-EUR exchange rate for delivery of a specified amount of foreign currency on a specified date. The currency forward agreements are typically cash settled in U.S. Dollars for their fair value at or close to their settlement date. Cross-currency swaps involve the receipt of functional-currency-fixed-rate amounts from a counterparty in exchange for the Company making foreign-currency fixed-rate payments over the life of the agreement.

For derivatives designated as net investment hedges, the gain or loss on the derivative is reported in AOCL as part of the cumulative translation adjustment. Amounts are reclassified out of AOCL into earnings when the hedged net investment is either sold or substantially liquidated.

As of March 31, 2021, the Company had the following outstanding foreign currency derivatives that were used to hedge its net investments in foreign operations:


Foreign Currency Derivative	Number of Instruments	Notional Sold	Notional Purchased
Cross-currency swap	2	€76,969	$83,225

Non-Designated Hedges

Derivatives not designated as hedges are not speculative and are used to manage the Company’s exposure to interest rate movements and other identified risks but do not meet the strict hedge accounting requirements and/or the Company has not elected to apply hedge accounting. Changes in the fair value of derivatives not designated in hedging relationships are recorded directly in earnings.

As of March 31, 2021, the Company had no outstanding derivatives that were not designated as hedges in qualifying hedging relationships.

Designated Hedges

The following table presents the fair value of the Company’s derivative financial instruments as well as their classification on the Consolidated Balance Sheet as of March 31, 2021:


	Asset Derivatives			Liability Derivatives
	Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value
Derivatives designated as hedging instruments:
Interest rate swaps	Prepaid expenses and other current assets	$	9	Accrued expenses and other current liabilities / Other noncurrent liabilities	$	313
Cross-currency swaps	Prepaid expenses and other current assets	673		Other noncurrent liabilities	10,518

Total derivatives designated as hedging instruments		$	682		$	10,831

The following table presents the fair value of the Company’s derivative financial instruments as well as their classification on the Consolidated Balance Sheet as of June 30, 2020:


	Asset Derivatives			Liability Derivatives
	Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value
Derivatives designated as hedging instruments:
Interest rate swaps	Prepaid expenses and other current assets	$	—	Accrued expenses and other current liabilities / Other noncurrent liabilities	$	856
Cross-currency swaps	Prepaid expenses and other current assets	746		Other noncurrent liabilities	5,475
Foreign currency forward contracts	Prepaid expenses and other current assets	75		Other noncurrent liabilities	—
Total derivatives designated as hedging instruments		$	821		$	6,331

Derivatives not designated as hedging instruments:
Foreign currency forward contracts	Prepaid expenses and other current assets	193		Accrued expenses and other current liabilities	74
Total derivative instruments		$	1,014		$	6,405

The following table presents the pre-tax effect of cash flow hedge accounting on AOCL as of the three months ended March 31, 2021 and 2020:


Derivatives in Cash Flow Hedging Relationships	Amount of Gain (Loss) Recognized in OCI on Derivatives				Location of Gain (Loss) Reclassified from AOCL into Income	Amount of Gain (Loss) Reclassified from AOCL into Income
	Three Months Ended March 31,					Three Months Ended March 31,
	2021		2020			2021		2020
Interest rate swaps	$	217	$	—	Interest and other financing expense, net	$	(82)	$	—
Cross-currency swaps	1,262		—		Interest and other financing expense, net / Other expense (income), net	1,239		—
Foreign currency forward contracts	—		134		Cost of sales	—		$	—
Total	$	1,479	$	134		$	1,157	$	—

The following table presents the pre-tax effect of cash flow hedge accounting on AOCL as of the nine months ended March 31, 2021 and 2020:


Derivatives in Cash Flow Hedging Relationships	Amount of Gain (Loss) Recognized in OCI on Derivatives				Location of Gain (Loss) Reclassified from AOCL into Income	Amount of Gain (Loss) Reclassified from AOCL into Income
	Nine Months Ended March 31,					Nine Months Ended March 31,
	2021		2020			2021		2020
Interest rate swaps	$	341	$	—	Interest and other financing expense, net	$	(212)	$	—
Cross-currency swaps	(1,124)		—		Interest and other financing expense, net / Other expense (income), net	(1,120)		—
Foreign currency forward contracts	(2)		128		Cost of sales	73		26
Total	$	(785)	$	128		$	(1,259)	$	26

The following table presents the pre-tax effect of the Company’s derivative financial instruments electing cash flow hedge accounting on the Consolidated Statements of Operations for the three months ended of March 31, 2021 and 2020:


				Location and Amount of Gain (Loss) Recognized in the Consolidated Statement of Operations on Cash Flow Hedging Relationships
				Three Months Ended March 31, 2021						Three Months Ended March 31, 2020
				Cost of sales		Interest and other financing expense, net		Other expense/income, net		Cost of sales		Interest and other financing expense, net		Other expense/income, net
The effects of cash flow hedging:
	(Loss) gain on cash flow hedging relationships
		Interest rate swaps
			Amount of (loss) reclassified from AOCL into expense	$	—	$	(82)	$	—	$	—	$	—	$	—

		Cross-currency swaps
			Amount of gain reclassified from AOCL into income	$	—	$	39	$	1,200	$	—	$	—	$	—

		Foreign currency forward contracts
			Amount of gain reclassified from AOCL into income	$	—	$	—	$	—	$	—	$	—	$	—


				Location and Amount of Gain (Loss) Recognized in the Consolidated Statement of Operations on Cash Flow Hedging Relationships
				Nine Months Ended March 31, 2021						Nine Months Ended March 31, 2020
				Cost of sales		Interest and other financing expense, net		Other expense (income), net		Cost of sales		Interest and other financing expense, net		Other expense (income), net
The effects of cash flow hedging:
	(Loss) gain on cash flow hedging relationships
		Interest rate swaps
			Amount of (loss) gain reclassified from AOCL into expense	$	—	$	(212)	$	—	$	—	$	—	$	—

		Cross-currency swaps
			Amount of gain (loss) reclassified from AOCL into income (expense)	$	—	$	120	$	(1,240)	$	—	$	—	$	—

		Foreign currency forward contracts
			Amount of gain reclassified from AOCL into income	$	73	$	—	$	—	$	26	$	—	$	—

The following table presents the pre-tax effect of the Company’s net investment hedges on AOCL and the Consolidated Statements of Operations for the three months ended March 31, 2021 and 2020:


Derivatives in Net Investment Hedging Relationships	Amount of Gain (Loss) Recognized in OCI on Derivatives				Location of Gain (Loss) Recognized in Income on Derivatives (Amount Excluded from Effectiveness Testing)	Amount of Gain (Loss) Recognized in Income on Derivatives (Amount Excluded from Effectiveness Testing)
	Three Months Ended March 31,					Three Months Ended March 31,
	2021		2020			2021		2020
Cross-currency swaps	$	3,933	$	—	Interest and other financing expense, net	$	123	$	—

The following table presents the pre-tax effect of the Company’s net investment hedges on AOCL and the Consolidated Statements of Operations for the nine months ended March 31, 2021 and 2020:


Derivatives in Net Investment Hedging Relationships	Amount of Gain (Loss) Recognized in OCI on Derivatives				Location of Gain (Loss) Recognized in Income on Derivatives (Amount Excluded from Effectiveness Testing)	Amount of Gain (Loss) Recognized in Income on Derivatives (Amount Excluded from Effectiveness Testing)
	Nine Months Ended March 31,					Nine Months Ended March 31,
	2021		2020			2021		2020
Cross-currency swaps	$	(3,498)	$	—	Interest and other financing expense, net	$	377	$	—

Non-Designated Hedges

The following table presents the effect of the Company’s derivative financial instruments that are not designated as hedging instruments on the Consolidated Statements Operations for the three months ended March 31, 2021 and 2020:


Derivatives Not Designated as Hedging Instruments	Location of Gain (Loss) Recognized in Income on Derivative	Amount of Gain (Loss) Recognized in Income on Derivatives
		Three Months Ended March 31,
		2021		2020
Foreign currency forward contracts	Other (income) expense, net	$	—	$	(336)


Derivatives Not Designated as Hedging Instruments	Location of Gain (Loss) Recognized in Income on Derivative	Amount of Gain (Loss) Recognized in Income on Derivatives
		Nine Months Ended March 31,
		2021		2020
Foreign currency forward contracts	Other (income) expense, net	$	(399)	$	(505)

Credit-Risk-Related Contingent Features

The Company has agreements with each of its derivative counterparties that contain a provision providing that upon certain defaults by the Company on any of its indebtedness, the Company could also be declared in default on its derivative obligations.

DISPOSITIONS (Assets and Liabilities Held for Sale) (Details) - USD ($) $ in Thousands	Mar. 31, 2021	Jan. 13, 2021	Jun. 30, 2020
ASSETS
Total assets	$ 0		$ 8,334
LIABILITIES
Total liabilities	$ 0		$ 3,567
Fruit Business \| Disposed of by Sale
ASSETS
Cash and cash equivalents		$ 13,559
Accounts receivable, less allowance for doubtful accounts		14,057
Inventories		5,028
Prepaid expenses and other current assets		2,728
Property, plant and equipment, net		25,039
Goodwill		14,362
Operating lease right-of-use assets		5,623
Allowance for reduction of assets held for sale		(58,444)
Total assets		58,123
LIABILITIES
Accounts payable		14,428
Accrued expenses and other current liabilities		4,229
Operating lease liabilities		5,039
Deferred tax liabilities		7,298
Other liabilities		1,942
Total liabilities		32,936
Fruit Business \| Disposed of by Sale \| Customer-Related Intangible Assets
ASSETS
Other intangible assets, net		$ 36,171

SEGMENT INFORMATION (Long-lived Assets) (Details) - USD ($) $ in Thousands	Mar. 31, 2021	Jun. 30, 2020
Segment Reporting Information [Line Items]
Long-lived assets	$ 423,735	$ 401,879
United States
Segment Reporting Information [Line Items]
Long-lived assets	165,516	146,633
United Kingdom
Segment Reporting Information [Line Items]
Long-lived assets	148,929	149,943
All Other
Segment Reporting Information [Line Items]
Long-lived assets	$ 109,290	$ 105,303

BASIS OF PRESENTATION (Details) - USD ($) $ in Thousands		12 Months Ended
BASIS OF PRESENTATION (Details) - USD ($) $ in Thousands	Jul. 01, 2020	Jun. 30, 2020	Jun. 30, 2019	Mar. 31, 2021	Dec. 31, 2020	Sep. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Sep. 30, 2019
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Cumulative effect of adoption of accounting standard		$ 1,443,554	$ 1,519,319	$ 1,501,682	$ 1,454,649	$ 1,436,581	$ 1,439,048	$ 1,521,083	$ 1,470,938
Accounting Standards Update	us-gaap:AccountingStandardsUpdate201613Member	us-gaap:AccountingStandardsUpdate201613Member	us-gaap:AccountingStandardsUpdate201602Member
Retained Earnings
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Cumulative effect of adoption of accounting standard		$ 614,171	$ 695,017	$ 650,740	$ 616,486	$ 614,346	$ 610,932	$ 586,593	$ 587,557
Cumulative Effect, Period of Adoption, Adjustment
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Cumulative effect of adoption of accounting standard		(310)	(439)
Cumulative Effect, Period of Adoption, Adjustment \| Retained Earnings
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Cumulative effect of adoption of accounting standard		$ (310)	$ (439)

- Definition

Indicates amendment to accounting standards.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 40
-Section 65
-Paragraph 2
-Subparagraph (f)(2)
-URI http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 40
-Section 65
-Paragraph 2
-Subparagraph (g)(1)
-URI http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 65
-Paragraph 15
-Subparagraph (f)(2)
-URI http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 326
-SubTopic 10
-Section 65
-Paragraph 4
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 65
-Paragraph 15
-Subparagraph (f)(1)
-URI http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 40
-Section 65
-Paragraph 2
-Subparagraph (g)(2)(i)
-URI http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 40
-Section 65
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 65
-Paragraph 15
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 326
-SubTopic 10
-Section 65
-Paragraph 4
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 65
-Paragraph 15
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 40
-Section 65
-Paragraph 2
-Subparagraph (h)(2)
-URI http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 40
-Section 65
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 326
-SubTopic 10
-Section 65
-Paragraph 4
-Subparagraph (e)(3)
-URI http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 65
-Paragraph 15
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 40
-Section 65
-Paragraph 2
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(4)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(3)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 40
-Section 65
-Paragraph 2
-Subparagraph (g)(2)(iv)
-URI http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 40
-Section 65
-Paragraph 2
-Subparagraph (g)(2)(iii)
-URI http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 40
-Section 65
-Paragraph 2
-Subparagraph (h)(1)
-URI http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 65
-Paragraph 15
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 65
-Paragraph 15
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333

Reference 24: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)(2)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 326
-SubTopic 10
-Section 65
-Paragraph 4
-Subparagraph (e)(4)
-URI http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 326
-SubTopic 10
-Section 65
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 65
-Paragraph 15
-Subparagraph (g)(2)
-URI http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 40
-Section 65
-Paragraph 2
-Subparagraph (f)(1)
-URI http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 326
-SubTopic 10
-Section 65
-Paragraph 4
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 40
-Section 65
-Paragraph 2
-Subparagraph (g)(2)(ii)
-URI http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 65
-Paragraph 8
-Subparagraph (d)(2)

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 65
-Paragraph 8
-Subparagraph (d)(3)

+ Details

- Definition

Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.

+ References + Details

INVESTMENTS	9 Months Ended
INVESTMENTS	Mar. 31, 2021
Equity Method Investments and Joint Ventures [Abstract]
INVESTMENTS	INVESTMENTS On October 27, 2015, the Company acquired a minority equity interest in Chop’t Creative Salad Company LLC, predecessor to Chop't Holdings, LLC (“Chop’t”). Chop’t develops and operates fast-casual, fresh salad restaurants in the Northeast and Mid-Atlantic United States. The investment is being accounted for as an equity method investment due to the Company’s representation on the Board of Directors of Chop’t. At March 31, 2021 and June 30, 2020, the carrying value of the Company’s investment in Chop’t was $11,098 and $12,793, respectively, and is included in the Consolidated Balance Sheets as a component of Investments and joint ventures. The Company also holds the following investments: (a) Hutchison Hain Organic Holdings Limited, a joint venture with Hutchison China Meditech Ltd., accounted for under the equity method of accounting, (b) Hain Future Natural Products Private Ltd., a joint venture with Future Consumer Ltd, accounted for under the equity method of accounting, and (c) Yeo Hiap Seng Limited, in which the Company holds a less than 1% equity ownership interest. The carrying value of these combined investments was $6,244 and $4,646 as of March 31, 2021 and June 30, 2020, respectively, and is included in the Consolidated Balance Sheets as a component of Investments and joint ventures.

LEASES (Other Information) (Details) - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$ 12,954	$ 12,856
Operating cash flows from finance leases	13	18
Financing cash flows from finance leases	285	372
ROU assets obtained in exchange for lease obligation:
Right-of-use assets obtained in exchange for lease obligations, Operating leases	18,349	94,389
Right-of-use assets obtained in exchange for lease obligations, Finance leases	$ 671	$ 1,092
Weighted average remaining lease term:
Weighted average remaining lease terms, Operating leases (in years)	10 years	8 years 4 months 24 days
Weighted average remaining lease terms, Finance leases (in years)	4 years 1 month 6 days	2 years 3 months 18 days
Weighted average discount rate: [Abstract]
Weighted average discount rates, Operating leases	3.20%	2.70%
Weighted average discount rates, Finance leases	3.90%	2.90%
Cumulative Effect, Period of Adoption, Adjustment
Weighted average discount rate: [Abstract]
Leases, ROU assets		$ 87,414

STOCK-BASED COMPENSATION AND INCENTIVE PERFORMANCE PLANS (Tables)

9 Months Ended

Mar. 31, 2021

Share-based Payment Arrangement [Abstract]

Compensation Cost And Related Income Tax Benefits Recognized

Compensation cost and related income tax benefits recognized in the Consolidated Statements of Operations for stock-based compensation plans were as follows:


	Three Months Ended March 31,				Nine Months Ended March 31,
	2021		2020		2021		2020
Selling, general and administrative expense	$	3,698	$	3,761	$	11,888	$	9,581

Discontinued operations	—		—		—		544
Total compensation cost recognized for stock-based compensation plans	$	3,698	$	3,761	$	11,888	$	10,125
Related income tax benefit	$	441	$	630	$	1,447	$	1,300

Non-Vested Restricted Stock And Restricted Share Unit Awards

A summary of the restricted stock activity (including all RSAs, RSUs and PSUs) for the nine months ended March 31, 2021 is as follows:


	Number of Shares and Units	Weighted Average Grant Date Fair Value (per share)
Non-vested RSAs, RSUs and PSUs outstanding at June 30, 2020	2,049	$	15.85
Granted	206	$	35.45
Vested	(333)	$	23.58
Forfeited	(109)	$	16.50
Non-vested RSAs, RSUs and PSUs outstanding at March 31, 2021	1,813	$	16.59

Restricted Stock Grant Information


	Nine Months Ended March 31,
	2021		2020
Fair value of RSAs, RSUs and PSUs granted	$	7,298	$	16,634
Fair value of shares vested	$	12,266	$	5,848
Tax benefit recognized from restricted shares vesting	$	1,786	$	(102)

DEBT AND BORROWINGS

9 Months Ended

Mar. 31, 2021

Debt Disclosure [Abstract]

DEBT AND BORROWINGS

Debt and borrowings consisted of the following:


	March 31, 2021		June 30, 2020
Revolving credit facility	$	255,000	$	280,000


Other borrowings	1,239		2,774
	256,239		282,774
Short-term borrowings and current portion of long-term debt	699		1,656
Long-term debt, less current portion	$	255,540	$	281,118

Credit Agreement

On February 6, 2018, the Company entered into the Third Amended and Restated Credit Agreement (as amended, the “Credit Agreement”). The Credit Agreement provides for a $1,000,000 revolving credit facility through February 6, 2023 and provided for a $300,000 term loan. Under the Credit Agreement, the revolving credit facility may be increased by an additional uncommitted $400,000, provided certain conditions are met.

Borrowings under the Credit Agreement may be used to provide working capital, finance capital expenditures and permitted acquisitions, refinance certain existing indebtedness and for other lawful corporate purposes. The Credit Agreement provides for multicurrency borrowings in Euros, Pounds Sterling and Canadian dollars as well as other currencies which may be designated. In addition, certain wholly-owned foreign subsidiaries of the Company may be designated as co-borrowers. The Credit Agreement contains restrictive covenants, which are usual and customary for facilities of its type, and include, with specified exceptions, limitations on the Company’s ability to engage in certain business activities, incur debt, have liens, make capital expenditures, pay dividends or make other distributions, enter into affiliate transactions, consolidate, merge or acquire or dispose of assets, and make certain investments, acquisitions and loans. The Credit Agreement also requires the Company to satisfy certain financial covenants. Obligations under the Credit Agreement are guaranteed by certain existing and future domestic subsidiaries of the Company. As of March 31, 2021, there were $255,000 of borrowings outstanding under the revolving credit facility and $6,394 letters of credit outstanding under the Credit Agreement. In the nine months ended March 31, 2020, the Company used the proceeds from the sale of Tilda, net of transaction costs, to prepay the entire principal amount of term loan outstanding under its credit facility and to partially pay down its revolving credit facility. In connection with the prepayment, the Company wrote off unamortized deferred debt issuance costs of $973, recorded in Interest and other financing expense, net in the Consolidated Statements of Operations.

On May 8, 2019, the Company entered into the Third Amendment to the Third Amended and Restated Credit Agreement (the “Amended Credit Agreement”), whereby, among other things, its allowable consolidated leverage ratio (as defined in the Credit Agreement) and interest coverage ratio (as defined in the Credit Agreement) were adjusted. The Company’s allowable consolidated leverage ratio is no more than 3.75 to 1.0 from March 31, 2021 and thereafter. Additionally, the Company’s required consolidated interest coverage ratio was no less than 3.75 to 1 through March 31, 2021 and no less than 4.0 to 1 thereafter.

The Amended Credit Agreement also required that the Company and the subsidiary guarantors enter into a Security and Pledge Agreement pursuant to which all of the obligations under the Amended Credit Agreement are secured by liens on assets of the Company and its material domestic subsidiaries, including stock of each of their direct subsidiaries and intellectual property, subject to agreed upon exceptions.

As of March 31, 2021, $738,606 was available under the Amended Credit Agreement, and the Company was in compliance with all associated covenants, as amended by the Amended Credit Agreement.

The Amended Credit Agreement provides that loans will bear interest at rates based on (a) the Eurocurrency Rate, as defined in the Credit Agreement, plus a rate ranging from 0.875% to 2.50% per annum; or (b) the Base Rate, as defined in the Credit Agreement, plus a rate ranging from 0.00% to 1.50% per annum, the relevant rate being the Applicable Rate. The Applicable Rate will be determined in accordance with a leverage-based pricing grid, as set forth in the Amended Credit Agreement. Swing Line loans and Global Swing Line loans denominated in U.S. dollars will bear interest at the Base Rate plus the Applicable Rate, and Global Swing Line loans denominated in foreign currencies shall bear interest based on the overnight Eurocurrency Rate for loans denominated in such currency plus the Applicable Rate. The weighted average interest rate on outstanding borrowings under the Amended Credit Agreement at March 31, 2021 was 1.11%. Additionally, the Amended Credit Agreement contains a Commitment Fee, as defined in the Amended Credit Agreement, on the amount unused under the Amended Credit Agreement ranging from 0.20% to 0.45% per annum, and such Commitment Fee is determined in accordance with a leverage-based pricing grid.

DEBT AND BORROWINGS (Tables)

9 Months Ended

Mar. 31, 2021

Debt Disclosure [Abstract]

Schedule of Debt And Borrowings

Debt and borrowings consisted of the following:


	March 31, 2021		June 30, 2020
Revolving credit facility	$	255,000	$	280,000


Other borrowings	1,239		2,774
	256,239		282,774
Short-term borrowings and current portion of long-term debt	699		1,656
Long-term debt, less current portion	$	255,540	$	281,118

- Definition

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(e),(f))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644

+ Details

PROPERTY, PLANT AND EQUIPMENT, NET

9 Months Ended

Mar. 31, 2021

Property, Plant and Equipment [Abstract]

PROPERTY, PLANT AND EQUIPMENT, NET

Property, plant and equipment, net consisted of the following:


	March 31, 2021		June 30, 2020
Land	$	14,561	$	13,866
Buildings and improvements	73,240		74,325
Machinery and equipment	317,270		288,466
Computer hardware and software	61,661		60,391
Furniture and fixtures	23,272		20,044
Leasehold improvements	39,009		40,876
Construction in progress	34,980		16,489
	563,993		514,457
Less: accumulated depreciation and amortization	252,651		225,201
	$	311,342	$	289,256

Depreciation expense for the three months ended March 31, 2021 and 2020 was $9,118 and $7,789, respectively. Depreciation expense for the nine months ended March 31, 2021 and 2020 was $26,302 and $23,518, respectively.

As of December 31, 2020, the Company reclassified $24,971 of Property, plant and equipment, net to Assets held for sale as part of the held for sale accounting related to the Company's Fruit business (see Note 4, Dispositions, for more information related to the held for sale assets). There was an impairment charge of $1,333 recorded during the nine months ended March 31, 2021 and no impairment charge recorded during the nine months ended March 31, 2020.

STOCK-BASED COMPENSATION AND INCENTIVE PERFORMANCE PLANS (Non-Vested Restricted Stock And Restricted Share Unit Awards) (Details) - RSAs, RSUs, and PSUs	9 Months Ended
	Mar. 31, 2021 $ / shares shares
Number of Shares and Units
Non-vested restricted stock, restricted share units, and performance units, beginning balance (shares)	2,049,000
Granted (shares)	206,000
Vested (shares)	(333,000)
Forfeited (shares)	(109,000)
Non-vested restricted stock, restricted share units, and performance units, ending balance (shares)	1,813,000
Weighted Average Grant Date Fair Value (per share)
Non-vested restricted stock, restricted share units, and performance units beginning balance (USD per share) \| $ / shares	$ 15.85
Granted (USD per share) \| $ / shares	35.45
Vested (USD per share) \| $ / shares	23.58
Forfeited (USD per share) \| $ / shares	16.50
Non-vested restricted stock, restricted share units, and performance units ending balance (USD per share) \| $ / shares	$ 16.59
Long Term Incentive Plan 2018-2020
Number of Shares and Units
Vested (shares)	(20,000)

EARNINGS (LOSS) PER SHARE (Tables)

9 Months Ended

Mar. 31, 2021

Earnings Per Share [Abstract]

Computation Of Basic And Diluted Earnings Per Share

The following table sets forth the computation of basic and diluted net income (loss) per share:


	Three Months Ended March 31,				Nine Months Ended March 31,
	2021		2020		2021		2020
Numerator:
Net income from continuing operations	$	34,254	$	25,036	$	25,624	$	21,935
Net (loss) income from discontinued operations	—		(697)		11,255		(105,581)
Net income (loss)	$	34,254	$	24,339	$	36,879	$	(83,646)

Denominator:
Basic weighted average shares outstanding	99,831		104,032		100,502		104,192
Effect of dilutive stock options, unvested restricted stock and unvested restricted share units	1,765		305		883		297
Diluted weighted average shares outstanding	101,596		104,337		101,385		104,489

Basic net income (loss) per common share:
Continuing operations	$	0.34	$	0.24	$	0.25	$	0.21
Discontinued operations	—		(0.01)		0.11		(1.01)
Basic net income (loss) per common share	$	0.34	$	0.23	$	0.36	$	(0.80)

Diluted net income (loss) per common share:
Continuing operations	$	0.34	$	0.24	$	0.25	$	0.21
Discontinued operations	—		(0.01)		0.11		(1.01)
Diluted net income (loss) per common share	$	0.34	$	0.23	$	0.36	$	(0.80)

DISPOSITIONS (Narrative) (Details) - USD ($)				1 Months Ended	3 Months Ended	9 Months Ended
DISPOSITIONS (Narrative) (Details) - USD ($)	Aug. 27, 2019	Jun. 28, 2019	Feb. 15, 2019	Jan. 31, 2020	Mar. 31, 2021	Mar. 31, 2021	Mar. 31, 2020	Jan. 13, 2021	Jun. 30, 2020
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Assets held for sale					$ 0	$ 0			$ 8,334,000
Liabilities related to assets held for sale					0	$ 0			3,567,000
Operating Segments \| Sales \| International
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Concentration risk, percentage						4.90%	8.60%
Fruit Business \| Disposed of by Sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Cash consideration to be received for sale of business					38,547,000	$ 38,547,000
Consideration receivable for sale of business					2,056,000	2,056,000
Pre-tax loss (gain) from reducing the carrying value to estimated fair value						56,093,000
Pre-tax loss on sale of business assets					1,904,000
Assets held for sale								$ 58,123,000
Liabilities related to assets held for sale								$ 32,936,000
Tilda \| Disposed of by Sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Proceeds from divestiture	$ 342,000,000			$ 341,800,000
Assets from discontinued operations					0	0			0
Liabilities held for sale					0	0			0
Hain Pure Protein \| Disposed of by Sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Assets from discontinued operations					0	0			0
Liabilities held for sale					$ 0	$ 0			$ 0
Plainville Farms \| Disposed of by Sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Proceeds from divestiture			$ 25,000,000
Letter of credit			$ 10,000,000
Expiration period (in months)			19 months
Percent of maximum draw			120.00%
HPPC and EK Holdings \| Disposed of by Sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Proceeds from divestiture		$ 77,714,000

EARNINGS (LOSS) PER SHARE

9 Months Ended

Mar. 31, 2021

Earnings Per Share [Abstract]

EARNINGS (LOSS) PER SHARE

The following table sets forth the computation of basic and diluted net income (loss) per share:


	Three Months Ended March 31,				Nine Months Ended March 31,
	2021		2020		2021		2020
Numerator:
Net income from continuing operations	$	34,254	$	25,036	$	25,624	$	21,935
Net (loss) income from discontinued operations	—		(697)		11,255		(105,581)
Net income (loss)	$	34,254	$	24,339	$	36,879	$	(83,646)

Denominator:
Basic weighted average shares outstanding	99,831		104,032		100,502		104,192
Effect of dilutive stock options, unvested restricted stock and unvested restricted share units	1,765		305		883		297
Diluted weighted average shares outstanding	101,596		104,337		101,385		104,489

Basic net income (loss) per common share:
Continuing operations	$	0.34	$	0.24	$	0.25	$	0.21
Discontinued operations	—		(0.01)		0.11		(1.01)
Basic net income (loss) per common share	$	0.34	$	0.23	$	0.36	$	(0.80)

Diluted net income (loss) per common share:
Continuing operations	$	0.34	$	0.24	$	0.25	$	0.21
Discontinued operations	—		(0.01)		0.11		(1.01)
Diluted net income (loss) per common share	$	0.34	$	0.23	$	0.36	$	(0.80)

Basic net income (loss) per share excludes the dilutive effects of stock options, unvested restricted stock and unvested restricted share units.

There were 4 and 512 restricted stock awards and stock options excluded from our calculation of diluted net income per share for the three months ended March 31, 2021 and 2020, respectively, as such awards were anti-dilutive. Additionally, there were 23 and 2,616 stock-based awards excluded for the three months ended March 31, 2021 and 2020, respectively, as such awards were contingently issuable based on market or performance conditions, and such conditions had not been achieved during the respective periods.

There were 182 and 450 restricted stock awards and stock options excluded from the calculation of diluted net income (loss) per share for the nine months ended March 31, 2021 and March 31, 2020, respectively, as such awards were anti-dilutive. Additionally, there were 957 and 2,685 stock-based awards excluded for the nine months ended March 31, 2021 and 2020, respectively, as such awards were contingently issuable based on market or performance conditions, and such conditions had not been achieved during the respective periods.

Share Repurchase Program

On June 21, 2017, the Company's Board of Directors authorized the repurchase of up to $250,000 of the Company’s issued and outstanding common stock. Repurchases may be made from time to time in the open market, pursuant to pre-set trading plans, in private transactions or otherwise. The authorization does not have a stated expiration date. The extent to which the Company repurchases its shares and the timing of such repurchases will depend upon market conditions and other corporate considerations. During the three months ended March 31, 2021, the Company repurchased 204 shares under the repurchase program for a total of $8,562, excluding commissions, at an average price of $41.86 per share. During the nine months ended March 31, 2021, the Company repurchased 2,408 shares under the repurchase program for a total of $80,255, excluding commissions, at an average price of $33.33 per share. As of March 31, 2021, the Company had $109,495 of remaining authorization under the share repurchase program.

INVENTORIES (Tables)

9 Months Ended

Mar. 31, 2021

Inventory Disclosure [Abstract]

Components of Inventories

Inventories consisted of the following:


	March 31, 2021		June 30, 2020
Finished goods	$	213,411	$	158,162
Raw materials, work-in-progress and packaging	100,487		90,008
	$	313,898	$	248,170

GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)

9 Months Ended

Mar. 31, 2021

Goodwill and Intangible Assets Disclosure [Abstract]

Changes In Carrying Amount Of Goodwill

The following table provides the changes in the carrying value of goodwill by reportable segment:


	North America		International		Total
Balance as of June 30, 2020 (a)	$	606,055	$	255,903	$	861,958


Reclassification of goodwill to assets held for sale	—		(14,362)		(14,362)

Translation and other adjustments, net	2,642		27,484		30,127
Balance as of March 31, 2021 (a)	$	608,697	$	269,025	$	877,723

(a) The total carrying value of goodwill is reflected net of $134,277 of accumulated impairment charges, of which $97,358 related to the Company’s United Kingdom operating segment, $29,219 related to the Company’s Europe operating segment and $7,700 related to the Company’s former Hain Ventures operating segment, whose goodwill and accumulated impairment charges were reallocated within the North America reportable segment to the United States and Canada operating segments on a relative fair value basis.

Other Intangible Assets

The following table includes the gross carrying amount and accumulated amortization, where applicable, for intangible assets, excluding goodwill:


	March 31, 2021		June 30, 2020
Non-amortized intangible assets:
Trademarks and tradenames (a)	$	280,690	$	278,103
Amortized intangible assets:
Other intangibles	148,422		184,854
Less: accumulated amortization	(104,321)		(116,495)
Net carrying amount	$	324,791	$	346,462

(a) The gross carrying value of trademarks and tradenames is reflected net of $93,273 of accumulated impairment charges as of both March 31, 2021 and June 30, 2020.

Other Intangible Assets

The following table includes the gross carrying amount and accumulated amortization, where applicable, for intangible assets, excluding goodwill:


	March 31, 2021		June 30, 2020
Non-amortized intangible assets:
Trademarks and tradenames (a)	$	280,690	$	278,103
Amortized intangible assets:
Other intangibles	148,422		184,854
Less: accumulated amortization	(104,321)		(116,495)
Net carrying amount	$	324,791	$	346,462

(a) The gross carrying value of trademarks and tradenames is reflected net of $93,273 of accumulated impairment charges as of both March 31, 2021 and June 30, 2020.

Finite-lived Intangible Assets Amortization Expense

Amortization expense included in continuing operations was as follows:


	Three Months Ended March 31,				Nine Months Ended March 31,
	2021		2020		2021		2020
Amortization of acquired intangibles	$	2,145	$	3,174	$	6,771	$	9,446

RELATED PARTY TRANSACTIONS	9 Months Ended
RELATED PARTY TRANSACTIONS	Mar. 31, 2021
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	RELATED PARTY TRANSACTIONS On April 15, 2021, the Company completed the divestiture of its North America non-dairy beverages brands, Dream® and WestSoy®, for $33,000 subject to customary post-closing adjustments. The purchaser in this transaction was SunOpta Inc. (“SunOpta”). The non-employee chair of the Company's Board of Directors is also the chair of the board of SunOpta. SunOpta is also one of the Company’s suppliers, for which the Company incurs expenses in the ordinary course of business. The Company incurred expenses of $3,649 and $2,513 in the three months ended March 31, 2021 and 2020, respectively, to SunOpta and its affiliated entities. For the nine months ended March 31, 2021 and 2020, the Company incurred expenses of $12,806 and $13,106, respectively, to SunOpta and its affiliated entities. A former member of the Company's Board of Directors is a partner in a law firm which provides legal services to the Company. The Company incurred expenses of $259 and $1,141 in the three months ended March 31, 2021 and 2020, respectively, and $1,476 and $3,629 in the nine months ended March 31, 2021 and 2020, respectively, to the law firm and affiliated entities. The director resigned from the Board in February 2020.

STOCK-BASED COMPENSATION AND INCENTIVE PERFORMANCE PLANS (Narrative) (Details) $ in Thousands	9 Months Ended
	Mar. 31, 2021 USD ($) plan shares	Jun. 30, 2020 shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shareholder-approved plans \| plan	1
RSAs, RSUs, and PSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for grant (in shares)	1,389,000	1,384,000
Vested restricted stock, restricted share units, and performance units (in shares)	333,000
RSAs, RSUs, and PSUs \| CEO
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for grant (in shares)		350,000
RSAs, RSUs, and PSUs \| Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percent of targeted award	0.00%
RSAs, RSUs, and PSUs \| Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percent of targeted award	300.00%
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized stock-based compensation expense \| $	$ 13,091
Period for recognition (in years)	1 year 2 months 12 days
Long Term Incentive Plan 2018-2020 \| RSAs, RSUs, and PSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percent of targeted award	150.00%
Vested restricted stock, restricted share units, and performance units (in shares)	20,000

BASIS OF PRESENTATION	9 Months Ended
BASIS OF PRESENTATION	Mar. 31, 2021
Accounting Policies [Abstract]
BASIS OF PRESENTATION	BASIS OF PRESENTATION The Company’s unaudited consolidated financial statements include the accounts of the Company and its wholly-owned and majority-owned subsidiaries. Intercompany accounts and transactions have been eliminated in consolidation. Investments in affiliated companies in which the Company exerts significant influence, but which it does not control, are accounted for under the equity method of accounting. As such, consolidated net loss includes the Company's equity in the current earnings or losses of such companies. The Company's unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by U.S. GAAP and should be read in conjunction with the Company's Annual Report on Form 10-K for the fiscal year ended June 30, 2020 (the “Form 10-K”). The amounts as of and for the periods ended June 30, 2020 are derived from the Company’s audited annual financial statements. The unaudited consolidated financial statements reflect all normal recurring adjustments which, in management’s opinion, are necessary for a fair presentation for interim periods. Operating results for the nine months ended March 31, 2021 are not necessarily indicative of the results that may be expected for the fiscal year ending June 30, 2021. Please refer to the Notes to the Consolidated Financial Statements as of June 30, 2020 and for the fiscal year then ended included in the Form 10-K for information not included in these condensed notes. All amounts in the unaudited consolidated financial statements, notes and tables have been rounded to the nearest thousand, except par values and per share amounts, unless otherwise indicated. Reclassifications Certain prior year amounts have been reclassified to conform with current year presentation. Significant Accounting Policies The Company's significant accounting policies are described in Note 2, Summary of Significant Accounting Policies and Practices, in the Notes to the Consolidated Financial Statements in the Form 10-K. Included herein are certain updates to those policies. Valuation of Accounts Receivable The Company maintains an allowance for expected uncollectible accounts receivable which is recorded as an offset to trade accounts receivable on the Consolidated Balance Sheets. Effective July 1, 2020, collectability of accounts receivable is assessed by applying a historical loss-rate methodology in accordance with Accounting Standards Codification ("ASC") Topic 326, Financial Instruments - Credit Losses, adjusted as necessary based on the Company's review of accounts receivable on an individual basis, specifically identifying customers with known disputes or collectability issues, and experience with trade receivable aging categories. The Company also considers market conditions and current and expected future economic conditions to inform adjustments to historical loss data. Changes to the allowance, if any, are classified as bad debt provisions in the Consolidated Statements of Operations. Recently Adopted Accounting Pronouncements In June 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2016-13, Measurement of Credit Losses on Financial Instruments, which requires measurement and recognition of expected versus incurred credit losses for most financial assets. The ASU applies to trade and other receivables recorded on the Consolidated Balance Sheets. The Company adopted the standard on July 1, 2020 using the modified retrospective transition method, recognizing an adjustment to beginning retained earnings of $310 reflecting the cumulative impact of adoption. The adoption did not materially impact the Company's results of operations or financial position, and as a result, comparisons between periods were not materially affected by the adoption of ASU 2016-13. In January 2017, the FASB issued ASU 2017-04, Simplifying the Test for Goodwill Impairment, which removes the second step of the goodwill impairment test that requires a hypothetical purchase price allocation. A goodwill impairment will now be the amount by which a reporting unit’s carrying value exceeds its fair value, not to exceed the carrying amount of goodwill. This guidance is effective for interim and annual reporting periods beginning after December 15, 2019. The Company adopted ASU 2017-04 on July 1, 2020, and the adoption of this standard did not have an impact on the Company’s consolidated financial statements. In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement: Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement, which modifies the disclosure requirements for fair value measurement by removing, modifying or adding certain disclosures. The new guidance is effective for annual periods beginning after December 15, 2019, and for interim periods within those fiscal years. The Company adopted ASU 2018-13 on July 1, 2020, and the adoption of this standard did not have an impact on the Company’s consolidated financial statements. In August 2018, the FASB issued ASU 2018-15, Intangibles - Goodwill and Other - Internal-Use Software, Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract, which aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The amended guidance is effective for annual periods beginning after December 15, 2019, and for interim periods within those fiscal years. The Company adopted ASU 2018-15 on July 1, 2020, and the adoption of this standard did not have an impact on the Company’s consolidated financial statements. Recently Issued Accounting Pronouncements Not Yet Effective In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which simplifies various aspects related to accounting for income taxes and eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating taxes during the quarters and the recognition of deferred tax liabilities for outside basis differences. The new guidance is effective for annual periods beginning after December 15, 2021, and for interim periods within those fiscal years. The Company is currently assessing the impact that this standard will have on its consolidated financial statements. In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides temporary optional expedients and exceptions for applying generally accepted accounting principles to contracts, hedging relationships and other transactions affected by reference rate reform. ASU 2020-04 is currently effective and upon adoption may be applied prospectively to contract modifications made on or before December 31, 2022. In January 2021, the FASB issued ASU 2021-01, Reference Rate Reform (Topic 848): Scope, which clarifies certain provisions in Topic 848, if elected by an entity, to apply to derivative instruments that use an interest rate for margining, discounting, or contract price alignment that is modified as a result of reference rate reform. The Company is currently assessing the impact that these standards will have on its consolidated financial statements. In October 2020, the FASB issued ASU 2020-10, Codification Improvements - Disclosures. This ASU improves consistency by amending the codification to include all disclosure guidance in the appropriate disclosure sections and clarifies application of various provisions in the codification by amending and adding new headings, cross referencing to other guidance, and refining or correcting terminology. This ASU is effective for fiscal years beginning after December 15, 2020. The Company is currently assessing the impact that this standard will have on its consolidated financial statements.

DERIVATIVES AND HEDGING ACTIVITIES (Cash Flow Hedges and Accumulated Other Comprehensive Loss) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Mar. 31, 2021	Mar. 31, 2020
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of Gain (Loss) Recognized in OCI on Derivatives	$ 1,479	$ 134	$ (785)	$ 128
Other (income) expense, net	(1,566)	260	852	(2,312)
Cost of sales	362,698	420,902	1,140,614	1,206,324
Reclassification out of Accumulated Other Comprehensive Income \| Accumulated Net Gain (Loss) from Cash Flow Hedges Including Portion Attributable to Noncontrolling Interest
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of Gain (Loss) Reclassified from AOCL into Income	1,157	0	(1,259)	26
Interest Rate Swap
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of Gain (Loss) Recognized in OCI on Derivatives	217	0	341	0
Interest Rate Swap \| Reclassification out of Accumulated Other Comprehensive Income \| Accumulated Net Gain (Loss) from Cash Flow Hedges Including Portion Attributable to Noncontrolling Interest
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Interest expense	(82)	0	(212)	0
Cross-currency swap
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of Gain (Loss) Recognized in OCI on Derivatives	1,262	0	(1,124)	0
Cross-currency swap \| Reclassification out of Accumulated Other Comprehensive Income \| Accumulated Net Gain (Loss) from Cash Flow Hedges Including Portion Attributable to Noncontrolling Interest
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Other (income) expense, net	1,239	0	(1,120)	0
Foreign currency forward contracts
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of Gain (Loss) Recognized in OCI on Derivatives	0	134	(2)	128
Foreign currency forward contracts \| Reclassification out of Accumulated Other Comprehensive Income \| Accumulated Net Gain (Loss) from Cash Flow Hedges Including Portion Attributable to Noncontrolling Interest
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Cost of sales	$ 0	$ 0	$ 73	$ 26

FINANCIAL INSTRUMENTS MEASURED AT FAIR VALUE

9 Months Ended

Mar. 31, 2021

Fair Value Disclosures [Abstract]

FINANCIAL INSTRUMENTS MEASURED AT FAIR VALUE

The Company’s financial assets and liabilities measured at fair value are required to be grouped in one of three levels. The levels prioritize the inputs used to measure the fair value of the assets or liabilities. These levels are:

•Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;

•Level 2 – Quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; and

•Level 3 – Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e., supported by little or no market activity).

The following table presents assets and liabilities measured at fair value on a recurring basis as of March 31, 2021:


	Total		Quoted prices in active markets (Level 1)		Significant other observable inputs (Level 2)		Significant unobservable inputs (Level 3)
Assets:

Derivative financial instruments	$	682	$	—	$	682	$	—
Equity investment	618		618		—		—
Total	$	1,300	$	618	$	682	$	—
Liabilities:
Derivative financial instruments	10,831		—		10,831		—
Total	$	10,831	$	—	$	10,831	$	—

The following table presents assets and liabilities measured at fair value on a recurring basis as of June 30, 2020:


	Total		Quoted prices in active markets (Level 1)		Significant other observable inputs (Level 2)		Significant unobservable inputs (Level 3)
Assets:
Cash equivalents	$	7	$	7	$	—	$	—
Derivative financial instruments	1,014		—		1,014		—
Equity investment	562		562		—		—
Total	$	1,583	$	569	$	1,014	$	—
Liabilities:
Derivative financial instruments	6,405		—		6,405		—

Total	$	6,405	$	—	$	6,405	$	—

The equity investment consists of the Company’s less than 1% investment in Yeo Hiap Seng Limited, a food and beverage manufacturer and distributor based in Singapore. Fair value is measured using the market approach based on quoted prices. The Company utilizes the income approach to measure fair value for its foreign currency forward contracts. The income approach uses pricing models that rely on market observable inputs such as yield curves, currency exchange rates and forward prices.

There were no transfers of financial instruments between the three levels of fair value hierarchy during the nine months ended March 31, 2021 or 2020.

The carrying amount of cash and cash equivalents, accounts receivable, net, accounts payable and certain accrued expenses and other current liabilities approximate fair value due to the short-term maturities of these financial instruments. The Company’s debt approximates fair value due to the debt bearing fluctuating market interest rates (see Note 9, Debt and Borrowings).

In addition to the instruments named above, the Company makes fair value measurements in connection with its assets and liabilities classified as held for sale, as these balances represent the estimated fair value, less costs to sell (See Note 4, Dispositions). The Company also makes fair value measurements in connection with its interim and annual goodwill and tradename impairment testing. These measurements fall into Level 3 of the fair value hierarchy (See Note 8, Goodwill and Other Intangible Assets).

Derivative Instruments

The Company uses interest rate swaps to manage its interest rate risk and cross-currency swaps and foreign currency exchange contracts to manage its exposure to fluctuations in foreign currency exchange rates. The valuation of these instruments is determined using widely accepted valuation techniques, including discounted cash flow analysis on the expected cash flows of each derivative. This analysis reflects the contractual terms of the derivatives, including the period to maturity, and uses observable market-based inputs, including interest rate curves and implied volatilities. The fair values of interest rate swaps are determined using the market standard methodology of netting the discounted future fixed cash receipts (or payments) and the discounted expected variable cash payments (or receipts). The variable cash payments (or receipts) are based on an expectation of future interest rates (forward curves) derived from observable market interest rate curves.

In accordance with the provisions of ASC 820, Fair Value Measurements, the Company incorporates credit valuation adjustments to appropriately reflect both the Company’s nonperformance risk and the respective counterparty’s nonperformance risk in the fair value measurements. In adjusting the fair value of the Company’s derivative contracts for the effect of nonperformance risk, the Company has considered the impact of netting and any applicable credit enhancements, such as collateral postings, thresholds, mutual puts and guarantees.

Although the Company has determined that the majority of the inputs used to value its derivatives fall within Level 2 of the fair value hierarchy, the credit valuation adjustments associated with its derivatives utilize Level 3 inputs, such as estimates of current credit spreads to evaluate the likelihood of default by the Company and its counterparties. The Company has determined that the significance of the impact of the credit valuation adjustments made to its derivative contracts, which determination was based on the fair value of each individual contract, was not significant to the overall valuation. As a result, all of the derivatives held as of March 31, 2021 and June 30, 2020 were classified as Level 2 of the fair value hierarchy.

The fair value estimates presented in the fair value hierarchy tables above are based on information available to management as of March 31, 2021 and June 30, 2020. These estimates are not necessarily indicative of the amounts we could ultimately realize.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

STOCK-BASED COMPENSATION AND INCENTIVE PERFORMANCE PLANS (Compensation Cost And Related Income Tax Benefits Recognized) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Mar. 31, 2021	Mar. 31, 2020
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total compensation cost recognized for stock-based compensation plans	$ 3,698	$ 3,761	$ 11,888	$ 10,125
Related income tax benefit	441	630	1,447	1,300
Selling, general and administrative expense
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	3,698	3,761	11,888	9,581
Discontinued operations
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	$ 0	$ 0	$ 0	$ 544

GOODWILL AND OTHER INTANGIBLE ASSETS (Narrative) (Details) $ in Thousands	9 Months Ended
	Mar. 31, 2021 USD ($)
Trademarks and Tradenames
Finite-Lived Intangible Assets [Line Items]
Annualized amortization expense	$ 914
Estimated useful lives (in years)	10 years
Minimum
Finite-Lived Intangible Assets [Line Items]
Estimated useful lives (in years)	3 years
Maximum
Finite-Lived Intangible Assets [Line Items]
Estimated useful lives (in years)	25 years

FINANCIAL INSTRUMENTS MEASURED AT FAIR VALUE (Narrative) (Details)	Mar. 31, 2021
Yeo Hiap Seng Limited
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Ownership percentage, less than	1.00%

FINANCIAL INSTRUMENTS MEASURED AT FAIR VALUE (Tables)

9 Months Ended

Mar. 31, 2021

Fair Value Disclosures [Abstract]

Assets And Liabilities Measured At Fair Value On A Recurring Basis

The following table presents assets and liabilities measured at fair value on a recurring basis as of March 31, 2021:


	Total		Quoted prices in active markets (Level 1)		Significant other observable inputs (Level 2)		Significant unobservable inputs (Level 3)
Assets:

Derivative financial instruments	$	682	$	—	$	682	$	—
Equity investment	618		618		—		—
Total	$	1,300	$	618	$	682	$	—
Liabilities:
Derivative financial instruments	10,831		—		10,831		—
Total	$	10,831	$	—	$	10,831	$	—

The following table presents assets and liabilities measured at fair value on a recurring basis as of June 30, 2020:


	Total		Quoted prices in active markets (Level 1)		Significant other observable inputs (Level 2)		Significant unobservable inputs (Level 3)
Assets:
Cash equivalents	$	7	$	7	$	—	$	—
Derivative financial instruments	1,014		—		1,014		—
Equity investment	562		562		—		—
Total	$	1,583	$	569	$	1,014	$	—
Liabilities:
Derivative financial instruments	6,405		—		6,405		—

Total	$	6,405	$	—	$	6,405	$	—

CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($) $ in Thousands	Mar. 31, 2021	Jun. 30, 2020
Current assets:
Cash and cash equivalents	$ 53,014	$ 37,771
Accounts receivable, less allowance for doubtful accounts of $1,178 and $638, respectively	190,737	170,969
Inventories	313,898	248,170
Prepaid expenses and other current assets	38,648	95,690
Assets held for sale	0	8,334
Total current assets	596,297	560,934
Property, plant and equipment, net	311,342	289,256
Goodwill	877,723	861,958
Trademarks and other intangible assets, net	324,791	346,462
Investments and joint ventures	17,342	17,439
Operating lease right-of-use assets	90,130	88,165
Other assets	22,263	24,238
Total assets	2,239,888	2,188,452
Current liabilities:
Accounts payable	210,223	171,009
Accrued expenses and other current liabilities	120,498	124,045
Current portion of long-term debt	699	1,656
Liabilities related to assets held for sale	0	3,567
Total current liabilities	331,420	300,277
Long-term debt, less current portion	255,540	281,118
Deferred income taxes	36,103	51,849
Operating lease liabilities, noncurrent portion	83,564	82,962
Other noncurrent liabilities	31,579	28,692
Total liabilities	738,206	744,898
Commitments and contingencies
Stockholders’ equity:
Preferred stock - $.01 par value, authorized 5,000 shares; issued and outstanding: none	0	0
Common stock - $.01 par value, authorized 150,000 shares; issued: 109,466 and 109,123 shares, respectively; outstanding: 99,706 and 101,885 shares, respectively	1,096	1,092
Additional paid-in capital	1,183,759	1,171,875
Retained earnings	650,740	614,171
Accumulated other comprehensive loss	(77,682)	(171,392)
Total stockholders' equity including treasury stock	1,757,913	1,615,746
Less: Treasury stock, at cost, 9,753 and 7,238 shares, respectively	(256,231)	(172,192)
Total stockholders’ equity	1,501,682	1,443,554
Total liabilities and stockholders’ equity	$ 2,239,888	$ 2,188,452

DERIVATIVES AND HEDGING ACTIVITIES (Tables)

9 Months Ended

Mar. 31, 2021

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Derivative Instruments

As of March 31, 2021, the Company had the following outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk:


Interest Rate Derivative	Number of Instruments	Notional Amount
Interest Rate Swap	4	$230,000

As of March 31, 2021, the Company had the following outstanding foreign currency derivatives that were used to hedge its foreign exchange risks:


Foreign Currency Derivative	Number of Instruments	Notional Sold	Notional Purchased
Cross-currency swap	1	€24,700	$26,775

As of March 31, 2021, the Company had the following outstanding foreign currency derivatives that were used to hedge its net investments in foreign operations:


Foreign Currency Derivative	Number of Instruments	Notional Sold	Notional Purchased
Cross-currency swap	2	€76,969	$83,225

Derivative Financial Instruments and Classification on Consolidated Balance Sheets

The following table presents the fair value of the Company’s derivative financial instruments as well as their classification on the Consolidated Balance Sheet as of March 31, 2021:


	Asset Derivatives			Liability Derivatives
	Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value
Derivatives designated as hedging instruments:
Interest rate swaps	Prepaid expenses and other current assets	$	9	Accrued expenses and other current liabilities / Other noncurrent liabilities	$	313
Cross-currency swaps	Prepaid expenses and other current assets	673		Other noncurrent liabilities	10,518

Total derivatives designated as hedging instruments		$	682		$	10,831

The following table presents the fair value of the Company’s derivative financial instruments as well as their classification on the Consolidated Balance Sheet as of June 30, 2020:


	Asset Derivatives			Liability Derivatives
	Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value
Derivatives designated as hedging instruments:
Interest rate swaps	Prepaid expenses and other current assets	$	—	Accrued expenses and other current liabilities / Other noncurrent liabilities	$	856
Cross-currency swaps	Prepaid expenses and other current assets	746		Other noncurrent liabilities	5,475
Foreign currency forward contracts	Prepaid expenses and other current assets	75		Other noncurrent liabilities	—
Total derivatives designated as hedging instruments		$	821		$	6,331

Derivatives not designated as hedging instruments:
Foreign currency forward contracts	Prepaid expenses and other current assets	193		Accrued expenses and other current liabilities	74
Total derivative instruments		$	1,014		$	6,405

Pre-Tax Effect of Cash Flow Hedge Accounting on Accumulated Other Comprehensive Loss

The following table presents the pre-tax effect of cash flow hedge accounting on AOCL as of the three months ended March 31, 2021 and 2020:


Derivatives in Cash Flow Hedging Relationships	Amount of Gain (Loss) Recognized in OCI on Derivatives				Location of Gain (Loss) Reclassified from AOCL into Income	Amount of Gain (Loss) Reclassified from AOCL into Income
	Three Months Ended March 31,					Three Months Ended March 31,
	2021		2020			2021		2020
Interest rate swaps	$	217	$	—	Interest and other financing expense, net	$	(82)	$	—
Cross-currency swaps	1,262		—		Interest and other financing expense, net / Other expense (income), net	1,239		—
Foreign currency forward contracts	—		134		Cost of sales	—		$	—
Total	$	1,479	$	134		$	1,157	$	—

The following table presents the pre-tax effect of cash flow hedge accounting on AOCL as of the nine months ended March 31, 2021 and 2020:


Derivatives in Cash Flow Hedging Relationships	Amount of Gain (Loss) Recognized in OCI on Derivatives				Location of Gain (Loss) Reclassified from AOCL into Income	Amount of Gain (Loss) Reclassified from AOCL into Income
	Nine Months Ended March 31,					Nine Months Ended March 31,
	2021		2020			2021		2020
Interest rate swaps	$	341	$	—	Interest and other financing expense, net	$	(212)	$	—
Cross-currency swaps	(1,124)		—		Interest and other financing expense, net / Other expense (income), net	(1,120)		—
Foreign currency forward contracts	(2)		128		Cost of sales	73		26
Total	$	(785)	$	128		$	(1,259)	$	26

Pre-Tax Effect of Derivative Financial Instruments Electing Cash Flow Hedge Accounting on Consolidated Statements of Operations


				Location and Amount of Gain (Loss) Recognized in the Consolidated Statement of Operations on Cash Flow Hedging Relationships
				Three Months Ended March 31, 2021						Three Months Ended March 31, 2020
				Cost of sales		Interest and other financing expense, net		Other expense/income, net		Cost of sales		Interest and other financing expense, net		Other expense/income, net
The effects of cash flow hedging:
	(Loss) gain on cash flow hedging relationships
		Interest rate swaps
			Amount of (loss) reclassified from AOCL into expense	$	—	$	(82)	$	—	$	—	$	—	$	—

		Cross-currency swaps
			Amount of gain reclassified from AOCL into income	$	—	$	39	$	1,200	$	—	$	—	$	—

		Foreign currency forward contracts
			Amount of gain reclassified from AOCL into income	$	—	$	—	$	—	$	—	$	—	$	—


				Location and Amount of Gain (Loss) Recognized in the Consolidated Statement of Operations on Cash Flow Hedging Relationships
				Nine Months Ended March 31, 2021						Nine Months Ended March 31, 2020
				Cost of sales		Interest and other financing expense, net		Other expense (income), net		Cost of sales		Interest and other financing expense, net		Other expense (income), net
The effects of cash flow hedging:
	(Loss) gain on cash flow hedging relationships
		Interest rate swaps
			Amount of (loss) gain reclassified from AOCL into expense	$	—	$	(212)	$	—	$	—	$	—	$	—

		Cross-currency swaps
			Amount of gain (loss) reclassified from AOCL into income (expense)	$	—	$	120	$	(1,240)	$	—	$	—	$	—

		Foreign currency forward contracts
			Amount of gain reclassified from AOCL into income	$	73	$	—	$	—	$	26	$	—	$	—

Pre-Tax Effect of Net Investment Hedges on Accumulated Other Comprehensive Loss and the Consolidated Statements of Operations

The following table presents the pre-tax effect of the Company’s net investment hedges on AOCL and the Consolidated Statements of Operations for the three months ended March 31, 2021 and 2020:


Derivatives in Net Investment Hedging Relationships	Amount of Gain (Loss) Recognized in OCI on Derivatives				Location of Gain (Loss) Recognized in Income on Derivatives (Amount Excluded from Effectiveness Testing)	Amount of Gain (Loss) Recognized in Income on Derivatives (Amount Excluded from Effectiveness Testing)
	Three Months Ended March 31,					Three Months Ended March 31,
	2021		2020			2021		2020
Cross-currency swaps	$	3,933	$	—	Interest and other financing expense, net	$	123	$	—

The following table presents the pre-tax effect of the Company’s net investment hedges on AOCL and the Consolidated Statements of Operations for the nine months ended March 31, 2021 and 2020:


Derivatives in Net Investment Hedging Relationships	Amount of Gain (Loss) Recognized in OCI on Derivatives				Location of Gain (Loss) Recognized in Income on Derivatives (Amount Excluded from Effectiveness Testing)	Amount of Gain (Loss) Recognized in Income on Derivatives (Amount Excluded from Effectiveness Testing)
	Nine Months Ended March 31,					Nine Months Ended March 31,
	2021		2020			2021		2020
Cross-currency swaps	$	(3,498)	$	—	Interest and other financing expense, net	$	377	$	—

Non-Designated Hedges

Pre-Tax Effect of Derivative Financial Instruments Not Designated as Hedging Instruments on the Consolidated Statements of Operations


Derivatives Not Designated as Hedging Instruments	Location of Gain (Loss) Recognized in Income on Derivative	Amount of Gain (Loss) Recognized in Income on Derivatives
		Three Months Ended March 31,
		2021		2020
Foreign currency forward contracts	Other (income) expense, net	$	—	$	(336)


Derivatives Not Designated as Hedging Instruments	Location of Gain (Loss) Recognized in Income on Derivative	Amount of Gain (Loss) Recognized in Income on Derivatives
		Nine Months Ended March 31,
		2021		2020
Foreign currency forward contracts	Other (income) expense, net	$	(399)	$	(505)

- Definition

Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4B
-URI http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1B
-URI http://asc.fasb.org/extlink&oid=121590274&loc=SL5580258-113959

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=121590274&loc=d3e41638-113959

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=121590274&loc=d3e41678-113959

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=121590274&loc=d3e41641-113959

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4C
-URI http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=121590274&loc=SL5579240-113959

+ Details

LEASES (Tables)

9 Months Ended

Mar. 31, 2021

Leases [Abstract]

Lease Expenses and Other Information

The components of lease expenses for the three and nine months ended March 31, 2021 were as follows:


	Three Months Ended				Nine Months Ended
	March 31, 2021		March 31, 2020		March 31, 2021		March 31, 2020
Operating lease expenses	$	4,129	$	4,545	$	12,290	$	14,034



Finance lease expenses	72		272		318		761
Variable lease expenses	247		633		1,204		1,873
Short-term lease expenses	458		490		1,701		1,349
Total lease expenses	$	4,906	$	5,940	$	15,513	$	18,017

Additional information related to leases is as follows:


	Nine Months Ended
	March 31, 2021			March 31, 2020
Supplemental cash flow information
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	12,954		$	12,856
Operating cash flows from finance leases	$	13		$	18
Financing cash flows from finance leases	$	285		$	372
ROU assets obtained in exchange for lease obligations (a):
Operating leases	$	18,349		$	94,389
Finance leases	$	671		$	1,092
Weighted average remaining lease term:
Operating leases	10.0 years			8.4 years
Finance leases	4.1 years			2.3 years
Weighted average discount rate:
Operating leases	3.2		%	2.7		%
Finance leases	3.9		%	2.9		%

(a) ROU assets obtained in exchange for lease obligations includes leases which commenced, were modified or terminated. The balance for the nine months ended March 31, 2020 also included $87,414 relating to the impact of the adoption of ASU 2016-02 effective July 1, 2019.

Supplemental Balance Sheet Information

Supplemental balance sheet information related to leases was as follows:


Leases	Classification	March 31, 2021		June 30, 2020
Assets
Operating lease ROU assets, net	Operating lease right-of-use assets	$	90,130	$	88,165

Finance lease ROU assets, net	Property, plant and equipment, net	615		691

Total leased assets		$	90,745	$	88,856

Liabilities
Current
Operating	Accrued expenses and other current liabilities	$	11,086	$	12,338

Finance	Current portion of long-term debt	245		308

Non-current
Operating	Operating lease liabilities, noncurrent portion	83,564		82,962
Finance	Long-term debt, less current portion	376		316
Total lease liabilities		$	95,271	$	95,924

Maturities of Lease Liabilities

Maturities of lease liabilities as of March 31, 2021 were as follows:


Fiscal Year	Operating leases		Finance leases		Total
2021 (remainder of year)	$	2,665	$	71	$	2,736
2022	14,358		246		14,604
2023	13,596		133		13,729
2024	11,878		51		11,929
2025	10,663		51		10,714
Thereafter	60,084		127		60,211
Total lease payments	113,244		679		113,923
Less: Imputed interest	18,594		58		18,652
Total lease liabilities	$	94,650	$	621	$	95,271

Maturities of lease liabilities as of June 30, 2020 were as follows:


Fiscal Year	Operating leases		Finance leases		Total
2021	$	14,781	$	308	$	15,089
2022	13,798		205		14,003
2023	12,833		95		12,928
2024	10,941		18		10,959
2025	9,521		6		9,527
Thereafter	51,545		—		51,545
Total lease payments	113,419		632		114,051
Less: Imputed interest	18,119		8		18,127
Total lease liabilities	$	95,300	$	624	$	95,924

Maturities of Lease Liabilities

Maturities of lease liabilities as of March 31, 2021 were as follows:


Fiscal Year	Operating leases		Finance leases		Total
2021 (remainder of year)	$	2,665	$	71	$	2,736
2022	14,358		246		14,604
2023	13,596		133		13,729
2024	11,878		51		11,929
2025	10,663		51		10,714
Thereafter	60,084		127		60,211
Total lease payments	113,244		679		113,923
Less: Imputed interest	18,594		58		18,652
Total lease liabilities	$	94,650	$	621	$	95,271

Maturities of lease liabilities as of June 30, 2020 were as follows:


Fiscal Year	Operating leases		Finance leases		Total
2021	$	14,781	$	308	$	15,089
2022	13,798		205		14,003
2023	12,833		95		12,928
2024	10,941		18		10,959
2025	9,521		6		9,527
Thereafter	51,545		—		51,545
Total lease payments	113,419		632		114,051
Less: Imputed interest	18,119		8		18,127
Total lease liabilities	$	95,300	$	624	$	95,924

LEASES (Lease Expense) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
LEASES (Lease Expense) (Details) - USD ($) $ in Thousands	Mar. 31, 2021	Mar. 31, 2020	Mar. 31, 2021	Mar. 31, 2020
Leases [Abstract]
Operating lease expenses	$ 4,129	$ 4,545	$ 12,290	$ 14,034
Finance lease expenses	72	272	318	761
Variable lease expenses	247	633	1,204	1,873
Short-term lease expenses	458	490	1,701	1,349
Total lease expenses	$ 4,906	$ 5,940	$ 15,513	$ 18,017

LEASES (Maturities of Lease Liabilities) (Details) - USD ($) $ in Thousands	Mar. 31, 2021	Jun. 30, 2020
Operating leases
Remainder of year	$ 2,665
Year One	14,358	$ 14,781
Year Two	13,596	13,798
Year Three	11,878	12,833
Year Four	10,663	10,941
Year Five		9,521
After Year Four, Thereafter	60,084
After Year Five, Thereafter		51,545
Total lease payments	113,244	113,419
Less: Imputed interest	18,594	18,119
Total lease liabilities	94,650	95,300
Finance leases
Remainder of year	71
Year One	246	308
Year Two	133	205
Year Three	51	95
Year Four	51	18
Year Five		6
After Year Four, Thereafter	127
After Year Five, Thereafter		0
Total lease payments	679	632
Less: Imputed interest	58	8
Total lease liabilities	621	624
Total
Remainder of year	2,736
Year One	14,604	15,089
Year Two	13,729	14,003
Year Three	11,929	12,928
Year Four	10,714	10,959
Year Five		9,527
After Year Four, Thereafter	60,211
After Year Five, Thereafter		51,545
Total lease payments	113,923	114,051
Less: Imputed interest	18,652	18,127
Total lease liabilities	$ 95,271	$ 95,924

STOCK-BASED COMPENSATION AND INCENTIVE PERFORMANCE PLANS

9 Months Ended

Mar. 31, 2021

Share-based Payment Arrangement [Abstract]

STOCK-BASED COMPENSATION AND INCENTIVE PERFORMANCE PLANS

The Company has one stockholder approved plan, the Amended and Restated 2002 Long-Term Incentive and Stock Award Plan (the "2002 Plan"), under which the Company’s officers, senior management, other key employees, consultants and directors may be granted equity-based awards. The Company also grants shares under its 2019 Equity Inducement Award Program (the "2019 Inducement Program") to induce selected individuals to become employees of the Company. The 2002 Plan and 2019 Inducement Program are collectively referred to as the "Stock Award Plans." In conjunction with the Stock Award Plans, the Company maintains a long-term incentive program (the “LTI Program”) that provides for performance and market equity awards that can be earned over defined performance periods. The Company's plans are described in Note 15, Stock-Based Compensation and Incentive Performance Plans, in the Notes to the Consolidated Financial Statements in the Form 10-K.

Compensation cost and related income tax benefits recognized in the Consolidated Statements of Operations for stock-based compensation plans were as follows:


	Three Months Ended March 31,				Nine Months Ended March 31,
	2021		2020		2021		2020
Selling, general and administrative expense	$	3,698	$	3,761	$	11,888	$	9,581

Discontinued operations	—		—		—		544
Total compensation cost recognized for stock-based compensation plans	$	3,698	$	3,761	$	11,888	$	10,125
Related income tax benefit	$	441	$	630	$	1,447	$	1,300

Restricted Stock

Awards of restricted stock are either restricted stock awards ("RSAs") or restricted stock units ("RSUs") that are issued at no cost to the recipient. Performance-based or market-based RSUs are issued in the form of performance share units ("PSUs"). A summary of the restricted stock activity (including all RSAs, RSUs and PSUs) for the nine months ended March 31, 2021 is as follows:


	Number of Shares and Units	Weighted Average Grant Date Fair Value (per share)
Non-vested RSAs, RSUs and PSUs outstanding at June 30, 2020	2,049	$	15.85
Granted	206	$	35.45
Vested	(333)	$	23.58
Forfeited	(109)	$	16.50
Non-vested RSAs, RSUs and PSUs outstanding at March 31, 2021	1,813	$	16.59

At March 31, 2021 and June 30, 2020, the table above includes a total of 1,389 and 1,384 shares (including an inducement grant of 350 shares made to the Company's CEO as previously disclosed), respectively, that represent the target number of shares that may be earned based on pre-defined market conditions and are eligible to vest ranging from zero to 300% of target. Vested shares during the current period include a total of 20 shares under the 2018-2020 LTIP that actually vested at 150% of target based on achievement of the maximum relative TSR target.


	Nine Months Ended March 31,
	2021		2020
Fair value of RSAs, RSUs and PSUs granted	$	7,298	$	16,634
Fair value of shares vested	$	12,266	$	5,848
Tax benefit recognized from restricted shares vesting	$	1,786	$	(102)

At March 31, 2021, there was $13,091 of unrecognized stock-based compensation expense related to non-vested restricted stock awards which is expected to be recognized over a weighted average period of 1.2 years.

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Mar. 31, 2021	Mar. 31, 2020
Statement of Comprehensive Income [Abstract]
Net income	$ 34,254	$ 24,339	$ 36,879	$ (83,646)
Pre-tax amount
Foreign currency translation adjustments before reclassifications	1,672	(52,315)	80,491	(42,602)
Reclassification of currency translation adjustment included in Net income from continuing operations, net of tax	14,725	0	15,906	95,120
Change in deferred gains (losses) on cash flow hedging instruments	322	134	474	108
Change in deferred gains (losses) on net investment hedging instruments	3,810	0	(3,875)	0
Total other comprehensive income (loss)	20,529	(52,181)	92,996	52,626
Tax (expense) benefit
Foreign currency translation adjustments before reclassifications	0	0	0	0
Reclassification of currency translation adjustment included in Net income from continuing operations, net of tax	0	0	0	0
Change in deferred gains (losses) on cash flow hedging instruments	(68)	(25)	(100)	(25)
Change in deferred gains (losses) on net investment hedging instruments	(800)	0	814	0
Total other comprehensive income (loss)	(868)	(25)	714	(25)
After-tax amount
Foreign currency translation adjustments before reclassifications	1,672	(52,315)	80,491	(42,602)
Reclassification of currency translation adjustment included in Net income from continuing operations, net of tax	14,725	0	15,906	95,120
Change in deferred gains (losses) on cash flow hedging instruments	254	109	374	83
Change in deferred gains (losses) on net investment hedging instruments	3,010	0	(3,061)	0
Total other comprehensive income (loss)	19,661	(52,206)	93,710	52,601
Total comprehensive income (loss)	$ 53,915	$ (27,867)	$ 130,589	$ (31,045)

BUSINESS (Details)	Mar. 31, 2021 country
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of countries in which entity operates (more than)	75

CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) - USD ($) $ in Thousands	Mar. 31, 2021	Jun. 30, 2020
Statement of Financial Position [Abstract]
Accounts receivable, allowance for doubtful accounts	$ 1,178	$ 638
Preferred stock, par value (USD per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized (shares)	5,000,000	5,000,000
Preferred stock, shares issued (shares)	0	0
Preferred stock, shares outstanding (shares)	0	0
Common stock, par value (USD per share)	$ 0.01	$ 0.01
Common stock, shares authorized (shares)	150,000,000	150,000,000
Common stock, shares issued (shares)	109,466,000	109,123,000
Common stock, shares, outstanding (shares)	99,706,000	101,885,000
Treasury stock, shares (shares)	9,753,000	7,238,000

Cover Page - shares	9 Months Ended
Cover Page - shares	Mar. 31, 2021	Apr. 29, 2021
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2021
Document Transition Report	false
Entity File Number	0-22818
Entity Registrant Name	THE HAIN CELESTIAL GROUP, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	22-3240619
Entity Address, Address Line One	1111 Marcus Avenue
Entity Address, City or Town	Lake Success
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	11042
City Area Code	516
Local Phone Number	587-5000
Title of 12(b) Security	Common Stock, par value $.01 per share
Trading Symbol	HAIN
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		99,720,275
Amendment Flag	false
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q3
Entity Central Index Key	0000910406
Current Fiscal Year End Date	--06-30

INVENTORIES (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
INVENTORIES (Details) - USD ($) $ in Thousands	Mar. 31, 2021	Mar. 31, 2020	Mar. 31, 2021	Mar. 31, 2020	Jun. 30, 2020
Inventory Disclosure [Abstract]
Finished goods	$ 213,411		$ 213,411		$ 158,162
Raw materials, work-in-progress and packaging	100,487		100,487		90,008
Total inventories	313,898		313,898		$ 248,170
Inventory write-down	$ 0	$ 1,362	$ 311	$ 5,278

INVENTORIES

9 Months Ended

Mar. 31, 2021

Inventory Disclosure [Abstract]

INVENTORIES

Inventories consisted of the following:


	March 31, 2021		June 30, 2020
Finished goods	$	213,411	$	158,162
Raw materials, work-in-progress and packaging	100,487		90,008
	$	313,898	$	248,170

At each period end, inventory is reviewed to ensure that it is recorded at the lower of cost or net realizable value. Inventory write-downs for the three months ended March 31, 2021 and March 31, 2020 were $0 and $1,362, respectively. Inventory write-downs for the nine months ended March 31, 2021 and March 31, 2020 were $311 and $5,278, respectively.

COMMITMENTS AND CONTINGENCIES (Details) - complaint			3 Months Ended
COMMITMENTS AND CONTINGENCIES (Details) - complaint	Apr. 26, 2017	Aug. 17, 2016	Mar. 31, 2021
Securities Complaints
Loss Contingencies [Line Items]
Number of complaints		3
Barnes Complaint
Loss Contingencies [Line Items]
Number of complaints	2
Baby Food Litigation \| Pending Litigation
Loss Contingencies [Line Items]
Number of complaints			25
Baby Food Litigation, Personal Injury \| Pending Litigation
Loss Contingencies [Line Items]
Number of complaints alleging injury			6
Number of complaints seeking relief			2

DISPOSITIONS (Tables)

9 Months Ended

Mar. 31, 2021

Discontinued Operations and Disposal Groups [Abstract]

Schedule of Disposal Groups, Including Discontinued Operations

At the Closing Date, the assets and liabilities of the Fruit business consisted of the following:


	January 13,
	2021
ASSETS
Cash and cash equivalents	$	13,559
Accounts receivable, less allowance for doubtful accounts	14,057
Inventories	5,028
Prepaid expenses and other current assets	2,728
Property, plant and equipment, net	25,039
Goodwill	14,362
Other intangible assets, net	36,171
Operating lease right-of-use assets	5,623
Allowance for reduction of assets held for sale	(58,444)
Total assets	$	58,123
LIABILITIES
Accounts payable	$	14,428
Accrued expenses and other current liabilities	4,229
Operating lease liabilities	5,039
Deferred tax liabilities	7,298
Other liabilities	1,942
Total liabilities	$	32,936

The following table presents the major classes of Tilda’s results within “Net income (loss) from discontinued operations, net of tax” in the Consolidated Statements of Operations:


	Three Months Ended March 31,				Nine Months Ended March 31,
	2021		2020		2021		2020
Net sales	$	—	$	—	$	—	$	30,399
Cost of sales	—		—		—		26,648
Gross profit	—		—		—		3,751
Selling, general and administrative expense	—		—		—		5,185

Other expense	—		—		75		1,172
Interest expense(1)	—		—		—		2,432
Translation loss(2)	—		—		—		95,120
Gain on sale of discontinued operations	—		540		—		(9,630)
Net loss from discontinued operations before income taxes	—		(540)		(75)		(90,528)
(Benefit) provision for income taxes(3)	—		(965)		(11,320)		12,900
Net income (loss) from discontinued operations, net of tax	$	—	$	425	$	11,245	$	(103,428)

(1) Interest expense was allocated to discontinued operations based on borrowings repaid with proceeds from the sale of Tilda.

(2) At the completion of the sale of Tilda, the Company reclassified $95,120 of related cumulative translation losses from Accumulated other comprehensive loss to discontinued operations, net of tax.

(3) Includes $11,320 of tax benefit related to the legal entity reorganization for the nine months ended March 31, 2021, as well as a tax benefit related to the gain on the sale of Tilda of $750 and tax expense of $14,500 for the three and nine months ended March 31, 2020, respectively.

The following table presents the major classes of Hain Pure Protein’s results within “Net loss (income) from discontinued operations, net of tax” in the Consolidated Statements of Operations:


	Three Months Ended March 31,				Nine Months Ended March 31,
	2021		2020		2021		2020
Net sales	$	—	$	—	$	—	$	—
Cost of sales	—		—		—		—
Gross profit (loss)	—		—		—		—
Selling, general and administrative expense	—		—		—		—
Asset impairments	—		—		—		—
Other income	—		—		(10)		—
Loss on sale of discontinued operations(1)	—		1,781		—		3,205
Net (loss) income from discontinued operations before income taxes	—		(1,781)		10		(3,205)
Benefit for income taxes	—		(659)		—		(1,052)
Net (loss) income from discontinued operations, net of tax	$	—	$	(1,122)	$	10	$	(2,153)

(1) Primarily relates to preliminary closing balance sheet adjustments.

- Definition

Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 3A
-URI http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5D
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 3A
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 4B
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5C
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5A
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5B
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760

Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 4A
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760

+ Details

STOCK-BASED COMPENSATION AND INCENTIVE PERFORMANCE PLANS (Restricted Stock Grant Information) (Details) - RSAs, RSUs, and PSUs - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value of RSAs, RSUs and PSUs granted	$ 7,298	$ 16,634
Fair value of shares vested	12,266	5,848
Tax benefit recognized from restricted shares vesting	$ 1,786	$ (102)

DERIVATIVES AND HEDGING ACTIVITIES (Not Designated as Hedging Instruments and Consolidated Statement of Operations) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Mar. 31, 2021	Mar. 31, 2020
Foreign currency forward contracts \| Not Designated as Hedging Instrument \| Other expense/income, net
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of Gain (Loss) Recognized in Income on Derivatives	$ 0	$ (336)	$ (399)	$ (505)

DERIVATIVES AND HEDGING ACTIVITIES (Net Investment Hedges and Accumulated Other Comprehensive Loss) (Details) - Cross-currency swap - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Mar. 31, 2021	Mar. 31, 2020
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of Gain (Loss) Recognized in OCI on Derivatives	$ 3,933	$ 0	$ (3,498)	$ 0
Net Investment Hedging \| Interest and other financing expense, net
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of Gain (Loss) Recognized in Income on Derivatives (Amount Excluded from Effectiveness Testing)	$ 123	$ 0	$ 377	$ 0

GOODWILL AND OTHER INTANGIBLE ASSETS

9 Months Ended

Mar. 31, 2021

Goodwill and Intangible Assets Disclosure [Abstract]

GOODWILL AND OTHER INTANGIBLE ASSETS

Goodwill

The following table provides the changes in the carrying value of goodwill by reportable segment:


	North America		International		Total
Balance as of June 30, 2020 (a)	$	606,055	$	255,903	$	861,958


Reclassification of goodwill to assets held for sale	—		(14,362)		(14,362)

Translation and other adjustments, net	2,642		27,484		30,127
Balance as of March 31, 2021 (a)	$	608,697	$	269,025	$	877,723

As of September 30 and December 31, 2020, Fruit, a part of the International reportable segment, was classified as held for sale and therefore, goodwill associated with Fruit was reclassified to Assets held for sale within the Consolidated Balance Sheet as of December 31, 2020. See Note 4, Dispositions, for more information. Fruit was a component of the Company's Hain Daniels reporting unit. The decision to sell the business was a triggering event requiring an interim goodwill impairment test for the Hain Daniels reporting unit. No impairment was recorded during the nine months ended March 31, 2021.

Other Intangible Assets

The following table includes the gross carrying amount and accumulated amortization, where applicable, for intangible assets, excluding goodwill:


	March 31, 2021		June 30, 2020
Non-amortized intangible assets:
Trademarks and tradenames (a)	$	280,690	$	278,103
Amortized intangible assets:
Other intangibles	148,422		184,854
Less: accumulated amortization	(104,321)		(116,495)
Net carrying amount	$	324,791	$	346,462

(a) The gross carrying value of trademarks and tradenames is reflected net of $93,273 of accumulated impairment charges as of both March 31, 2021 and June 30, 2020.

There were no events or circumstances that warranted an interim impairment test for indefinite-lived intangible assets during the nine months ended March 31, 2021 or 2020.

During the nine months ended March 31, 2021, the Company reclassified certain of its indefinite-lived intangible assets consisting of trademarks and tradenames to definite-lived intangible assets and began amortization of these assets. The annualized amortization expense of these assets is $914 and will amortize over an estimated useful life of 10 years.

Amortized intangible assets, which are deemed to have a finite life, primarily consist of customer relationships and certain trademarks and tradenames and are amortized over their estimated useful lives of 3 to 25 years. Amortization expense included in continuing operations was as follows:


	Three Months Ended March 31,				Nine Months Ended March 31,
	2021		2020		2021		2020
Amortization of acquired intangibles	$	2,145	$	3,174	$	6,771	$	9,446

PROPERTY, PLANT AND EQUIPMENT, NET (Details) - USD ($)	3 Months Ended		9 Months Ended
PROPERTY, PLANT AND EQUIPMENT, NET (Details) - USD ($)	Mar. 31, 2021	Mar. 31, 2020	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020	Jun. 30, 2020
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 563,993,000		$ 563,993,000			$ 514,457,000
Less: accumulated depreciation and amortization	252,651,000		252,651,000			225,201,000
Property, plant and equipment, net	311,342,000		311,342,000			289,256,000
Depreciation	9,118,000	$ 7,789,000	26,302,000	$ 23,518,000
Impairment charge			1,333,000	$ 0
Discontinued Operations, Held-for-sale \| Fruit Business
Property, Plant and Equipment [Line Items]
Disposal group, Property, plant and equipment					$ 24,971,000
Land
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	14,561,000		14,561,000			13,866,000
Buildings and improvements
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	73,240,000		73,240,000			74,325,000
Machinery and equipment
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	317,270,000		317,270,000			288,466,000
Computer hardware and software
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	61,661,000		61,661,000			60,391,000
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	23,272,000		23,272,000			20,044,000
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	39,009,000		39,009,000			40,876,000
Construction in progress
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 34,980,000		$ 34,980,000			$ 16,489,000

SEGMENT INFORMATION (Net Sales) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Mar. 31, 2021	Mar. 31, 2020
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	$ 492,604	$ 553,297	$ 1,519,649	$ 1,542,157
United States
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	251,887	279,534	735,947	758,759
United Kingdom
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	139,094	169,024	475,739	501,619
All Other
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	101,623	104,739	307,963	281,779
Grocery
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	322,107	373,723	1,030,544	1,081,497
Snacks
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	79,768	79,252	235,641	227,925
Personal Care
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	50,446	66,950	144,057	138,880
Tea
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	$ 40,283	$ 33,372	$ 109,407	$ 93,855

- Definition

Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 924
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 11.L)
-URI http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856

+ Details

DEBT AND BORROWINGS (Credit Agreement) (Details) - Amended Credit Agreement	3 Months Ended	9 Months Ended
	Jun. 30, 2021	Mar. 31, 2021 USD ($)	Mar. 31, 2020 USD ($)	Jun. 30, 2020 USD ($)	Feb. 06, 2018 USD ($)
Unsecured revolving credit facility
Line of Credit Facility [Line Items]
Revolving credit facility					$ 1,000,000,000
Line of credit facility outstanding		$ 255,000,000		$ 280,000,000
Letters of credit outstanding		$ 6,394,000
Write off of unamortized issuance costs			$ 973,000
Term Loan
Line of Credit Facility [Line Items]
Revolving credit facility					300,000,000
Additional borrowing capacity					$ 400,000,000
Consolidated leverage ratio		3.75
Interest coverage ratio		3.75
Available borrowing capacity		$ 738,606,000
Weighted average interest rate		1.11%
Term Loan \| Minimum
Line of Credit Facility [Line Items]
Commitment fee percentage		0.20%
Term Loan \| Maximum
Line of Credit Facility [Line Items]
Commitment fee percentage		0.45%
Term Loan \| Forecast
Line of Credit Facility [Line Items]
Interest coverage ratio	4.0
Term Loan \| Eurocurrency Rate \| Minimum
Line of Credit Facility [Line Items]
Basis spread on variable rate		0.875%
Term Loan \| Eurocurrency Rate \| Maximum
Line of Credit Facility [Line Items]
Basis spread on variable rate		2.50%
Term Loan \| Base Rate \| Minimum
Line of Credit Facility [Line Items]
Basis spread on variable rate		0.00%
Term Loan \| Base Rate \| Maximum
Line of Credit Facility [Line Items]
Basis spread on variable rate		1.50%

SEGMENT INFORMATION

9 Months Ended

Mar. 31, 2021

Segment Reporting [Abstract]

SEGMENT INFORMATION

In accordance with ASC 280, Segment Reporting, the Company, based on economic similarity, defines its operating segments as the following five segments: the United States, United Kingdom (Hain Daniels), Ella's Kitchen UK, Europe and Canada. Similarly, under the same guidance, the Company operates under two reportable segments: North America and International.

Net sales and operating income are the primary measures used by the Company’s chief operating decision maker ("CODM") to evaluate segment operating performance and to decide how to allocate resources to segments. The CODM is the Company’s CEO. Expenses related to certain centralized administration functions that are not specifically related to an operating segment are included in Corporate and Other expenses. Corporate and Other expenses are comprised mainly of the compensation and related expenses of certain of the Company’s senior executive officers and other selected employees who perform duties related to the entire enterprise, as well as expenses for certain professional fees, facilities and other items which benefit the Company as a whole. Additionally, certain Productivity and transformation costs are included in Corporate and Other. Expenses that are managed centrally, but can be attributed to a segment, such as employee benefits and certain facility costs, are allocated based on reasonable allocation methods. Information about total assets by segment is not disclosed because such information is not reported to or used by the Company’s CODM for purposes of assessing segment performance or allocating resources.

The following tables set forth financial information about each of the Company’s reportable segments. Transactions between reportable segments were insignificant for all periods presented.


	Three Months Ended March 31,				Nine Months Ended March 31,
	2021		2020		2021		2020
Net Sales:
North America	$	287,500	$	320,440	$	850,780	$	872,834
International	205,104		232,857		668,869		669,323

	$	492,604	$	553,297	$	1,519,649	$	1,542,157

Operating Income (Loss):
North America	$	39,492	$	28,873	$	105,188	$	64,067
International	26,774		18,660		8,144		40,666
	66,266		47,533		113,332		104,733
Corporate and Other (a)	(16,689)		(28,398)		(47,518)		(73,952)
	$	49,577	$	19,135	$	65,814	$	30,781

(a) In addition to general Corporate and Other expenses as described above, for the three months ended March 31, 2021, Corporate and Other included $2,804 of Productivity and transformation costs. For the three months ended March 31, 2020, Corporate and Other included $5,572 of Productivity and transformation costs and tradename impairment charges of $7,650 (related to North America).

For the nine months ended March 31, 2021, Corporate and Other included $6,343 of Productivity and transformation costs. For the nine months ended March 31, 2020, Corporate and Other included $26,142 of Productivity and transformation costs and tradename impairment charges of $9,539 ($4,007 related to North America; $5,532 related to International), partially offset by a benefit of $2,962 of proceeds from insurance claim.

The Company's net sales by product category are as follows:


	Three Months Ended March 31,				Nine Months Ended March 31,
	2021		2020		2021		2020
Grocery	$	322,107	$	373,723	$	1,030,544	$	1,081,497

Snacks	79,768		79,252		235,641		227,925
Personal Care	50,446		66,950		144,057		138,880
Tea	40,283		33,372		109,407		93,855
Total	$	492,604	$	553,297	$	1,519,649	$	1,542,157

The Company’s net sales by geographic region, which are generally based on the location of the Company’s subsidiaries, were as follows:


	Three Months Ended March 31,				Nine Months Ended March 31,
	2021		2020		2021		2020
United States	$	251,887	$	279,534	$	735,947	$	758,759
United Kingdom	139,094		169,024		475,739		501,619
All Other	101,623		104,739		307,963		281,779
Total	$	492,604	$	553,297	$	1,519,649	$	1,542,157

The Company’s long-lived assets, which primarily represent net property, plant and equipment, operating lease right-of-use assets and noncurrent other assets by geographic area were as follows:


	March 31, 2021		June 30, 2020
United States	$	165,516	$	146,633
United Kingdom	148,929		149,943
All Other	109,290		105,303
Total	$	423,735	$	401,879

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-URI http://asc.fasb.org/topic&trid=2134510

+ Details

DERIVATIVES AND HEDGING ACTIVITIES (Pre-Tax Effect of Derivative Financial Instruments) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Mar. 31, 2021	Mar. 31, 2020
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of Gain (Loss) Reclassified from AOCL into Income	$ 45,981	$ 15,358	$ 59,846	$ 13,401
Interest Rate Swap \| Cost of sales \| Reclassification out of Accumulated Other Comprehensive Income \| Accumulated Gain (Loss), Cash Flow Hedge, Including Noncontrolling Interest
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of Gain (Loss) Reclassified from AOCL into Income	0	0	0	0
Interest Rate Swap \| Interest and other financing expense, net \| Reclassification out of Accumulated Other Comprehensive Income \| Accumulated Gain (Loss), Cash Flow Hedge, Including Noncontrolling Interest
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of Gain (Loss) Reclassified from AOCL into Income	(82)	0	(212)	0
Interest Rate Swap \| Other expense/income, net \| Reclassification out of Accumulated Other Comprehensive Income \| Accumulated Gain (Loss), Cash Flow Hedge, Including Noncontrolling Interest
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of Gain (Loss) Reclassified from AOCL into Income	0	$ 0	0	0
Cross-currency swap \| Interest and other financing expense, net \| Reclassification out of Accumulated Other Comprehensive Income \| Accumulated Gain (Loss), Cash Flow Hedge, Including Noncontrolling Interest
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of Gain (Loss) Reclassified from AOCL into Income	39		120
Cross-currency swap \| Other expense/income, net \| Reclassification out of Accumulated Other Comprehensive Income \| Accumulated Gain (Loss), Cash Flow Hedge, Including Noncontrolling Interest
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of Gain (Loss) Reclassified from AOCL into Income	$ 1,200		(1,240)
Foreign currency forward contracts \| Cost of sales \| Reclassification out of Accumulated Other Comprehensive Income \| Accumulated Gain (Loss), Cash Flow Hedge, Including Noncontrolling Interest
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of Gain (Loss) Reclassified from AOCL into Income			$ 73	$ 26

ACCUMULATED OTHER COMPREHENSIVE LOSS

9 Months Ended

Mar. 31, 2021

Equity [Abstract]

ACCUMULATED OTHER COMPREHENSIVE LOSS

The following table presents the changes in accumulated other comprehensive loss ("AOCL"):


	Three Months Ended March 31,				Nine Months Ended March 31,
	2021		2020		2021		2020
Foreign currency translation adjustments:
Other comprehensive income (loss) before reclassifications (1)	$	1,672	$	(52,315)	$	80,491	$	(42,602)
Amounts reclassified into income (2)	14,725		—		15,906		95,120
Deferred gains (losses) on cash flow hedging instruments:

Amount of gain (loss) gain recognized in AOCL on derivatives (3)	1,168				(621)		—
Amount of (loss) gain reclassified from AOCL into (expense) income (3)	(914)		109		995		83
Deferred gains (losses) on net investment hedging instruments:

Amount of gain (loss) recognized in AOCL on derivatives (3)	3,107		—		(2,763)		—
Amount of loss reclassified from AOCL into expense (3)	(97)		—		(298)		—
Net change in AOCL	$	19,661	$	(52,206)	$	93,710	$	52,601

(1) Foreign currency translation adjustments included intra-entity foreign currency transactions that were of a long-term investment nature and were a net gain of $0 and $453 for the three months ended March 31, 2021 and 2020, respectively. Foreign currency translation adjustments included intra-entity foreign currency transactions that were of a long-term investment nature and were a net loss of $0 and $703 for the nine months ended March 31, 2021 and 2020, respectively.

(2) Foreign currency translation gains or losses of foreign subsidiaries related to divested businesses are reclassified into income once the liquidation of the respective foreign subsidiaries is substantially complete. At the completion of the sales of Danival and Fruit, the Company reclassified $15,906 of translation losses from accumulated comprehensive loss to the Company's results of operations. At the completion of the sale of Tilda, the Company reclassified $95,120 of translation losses from accumulated comprehensive loss to the Company’s results of discontinued operations.

(3) See Note 15, Derivatives and Hedging Activities, for the amounts reclassified into income for deferred gains (losses) on cash flow hedging instruments recorded in the Consolidated Statements of Operations in the three and nine months ended March 31, 2021 and 2020.

COMMITMENTS AND CONTINGENCIES	9 Months Ended
COMMITMENTS AND CONTINGENCIES	Mar. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	COMMITMENTS AND CONTINGENCIES Securities Class Actions Filed in Federal Court On August 17, 2016, three securities class action complaints were filed in the Eastern District of New York against the Company alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. The three complaints are: (1) Flora v. The Hain Celestial Group, Inc., et al. (the “Flora Complaint”); (2) Lynn v. The Hain Celestial Group, Inc., et al. (the “Lynn Complaint”); and (3) Spadola v. The Hain Celestial Group, Inc., et al. (the “Spadola Complaint” and, together with the Flora and Lynn Complaints, the “Securities Complaints”). On June 5, 2017, the court issued an order for consolidation, appointment of Co-Lead Plaintiffs and approval of selection of co-lead counsel. Pursuant to this order, the Securities Complaints were consolidated under the caption In re The Hain Celestial Group, Inc. Securities Litigation (the “Consolidated Securities Action”), and Rosewood Funeral Home and Salamon Gimpel were appointed as Co-Lead Plaintiffs. On June 21, 2017, the Company received notice that plaintiff Spadola voluntarily dismissed his claims without prejudice to his ability to participate in the Consolidated Securities Action as an absent class member. The Co-Lead Plaintiffs in the Consolidated Securities Action filed a Consolidated Amended Complaint on August 4, 2017 and a Corrected Consolidated Amended Complaint on September 7, 2017 on behalf of a purported class consisting of all persons who purchased or otherwise acquired Hain Celestial securities between November 5, 2013 and February 10, 2017 (the “Amended Complaint”). The Amended Complaint named as defendants the Company and certain of its former officers (collectively, “Defendants”) and asserted violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 based on allegedly materially false or misleading statements and omissions in public statements, press releases and SEC filings regarding the Company’s business, prospects, financial results and internal controls. Defendants filed a motion to dismiss the Amended Complaint on October 3, 2017 which the Court granted on March 29, 2019, dismissing the case in its entirety, without prejudice to replead. Co-Lead Plaintiffs filed a Second Amended Consolidated Class Action Complaint on May 6, 2019 (the “Second Amended Complaint”). The Second Amended Complaint again named as defendants the Company and certain of its former officers and asserts violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 based on allegations similar to those in the Amended Complaint, including materially false or misleading statements and omissions in public statements, press releases and SEC filings regarding the Company’s business, prospects, financial results and internal controls. Defendants filed a motion to dismiss the Second Amended Complaint on June 20, 2019. Co-Lead Plaintiffs filed an opposition on August 5, 2019, and Defendants submitted a reply on September 3, 2019. On April 6, 2020, the Court granted Defendants' motion to dismiss the Second Amended Complaint in its entirety, with prejudice. Co-Lead Plaintiffs filed a notice of appeal on May 5, 2020 indicating their intent to appeal the Court’s decision dismissing the Second Amended Complaint to the United States Court of Appeals for the Second Circuit. Co-Lead Plaintiffs filed their appellate brief on August 18, 2020. Defendants filed their opposition brief on November 17, 2020, and Plaintiffs filed their reply brief on December 8, 2020. Accordingly, Co-Lead Plaintiffs’ appeal is fully briefed. Oral argument has not yet been scheduled. Additional Stockholder Class Action and Derivative Complaints Filed in Federal Court On April 19, 2017 and April 26, 2017, two class action and stockholder derivative complaints were filed in the Eastern District of New York against the former Board of Directors and certain former officers of the Company under the captions Silva v. Simon, et al. (the “Silva Complaint”) and Barnes v. Simon, et al. (the “Barnes Complaint”), respectively. Both the Silva Complaint and the Barnes Complaint allege violation of securities law, breach of fiduciary duty, waste of corporate assets and unjust enrichment. On May 23, 2017, an additional stockholder filed a complaint under seal in the Eastern District of New York against the former Board of Directors and certain former officers of the Company. The complaint alleged that the Company’s former directors and certain former officers made materially false and misleading statements in press releases and SEC filings regarding the Company’s business, prospects and financial results. The complaint also alleged that the Company violated its by-laws and Delaware law by failing to hold its 2016 Annual Stockholders Meeting and includes claims for breach of fiduciary duty, unjust enrichment and corporate waste. On August 9, 2017, the Court granted an order to unseal this case and reveal Gary Merenstein as the plaintiff (the “Merenstein Complaint”). On August 10, 2017, the court granted the parties' stipulation to consolidate the Barnes Complaint, the Silva Complaint and the Merenstein Complaint under the caption In re The Hain Celestial Group, Inc. Stockholder Class and Derivative Litigation (the “Consolidated Stockholder Class and Derivative Action”) and to appoint Robbins Arroyo LLP and Scott+Scott as Co-Lead Counsel, with the Law Offices of Thomas G. Amon as Liaison Counsel for Plaintiffs. On September 14, 2017, a related complaint was filed under the caption Oliver v. Berke, et al. (the “Oliver Complaint”), and on October 6, 2017, the Oliver Complaint was consolidated with the Consolidated Stockholder Class and Derivative Action. The Plaintiffs filed their consolidated amended complaint under seal on October 26, 2017. On December 20, 2017, the parties agreed to stay Defendants’ time to answer, move, or otherwise respond to the consolidated amended complaint through and including 30 days after a decision was rendered on the motion to dismiss the Amended Complaint in the Consolidated Securities Action, described above. On March 29, 2019, the Court in the Consolidated Securities Action granted Defendants’ motion, dismissing the Amended Complaint in its entirety, without prejudice to replead. Co-Lead Plaintiffs in the Consolidated Securities Action filed the Second Amended Complaint on May 6, 2019. The parties to the Consolidated Stockholder Class and Derivative Action agreed to continue the stay of Defendants’ time to answer, move, or otherwise respond to the consolidated amended complaint through 30 days after a decision on Defendants' motion to dismiss the Second Amended Complaint in the Consolidated Securities Action. On April 6, 2020, the Court granted Defendants’ motion to dismiss the Second Amended Complaint in the Consolidated Securities Action, with prejudice. Pursuant to the terms of the stay, Defendants in the Consolidated Stockholder Class and Derivative Action had until May 6, 2020 to answer, move, or otherwise respond to the complaint in this matter. This deadline was extended, and Defendants moved to dismiss the Consolidated Stockholder Class and Derivative Action Complaint on June 23, 2020, with Plaintiffs’ opposition due August 7, 2020. On July 24, 2020, Plaintiffs made a stockholder litigation demand on the current Board containing overlapping factual allegations to those set forth in the Consolidated Stockholder Class and Derivative Action. On August 10, 2020, the Court vacated the briefing schedule on Defendants’ pending motion to dismiss in order to give the Board of Directors time to consider the demand. On each of September 8 and October 8, 2020, the Court extended its stay of any applicable deadlines for 30 days to give the Board of Directors additional time to complete its evaluation of the demand. On November 3, 2020, Plaintiffs were informed that the Board of Directors had finished investigating and resolved, among other things, that the demand should be rejected. On November 6, 2020, Plaintiffs and Defendants notified the Court that Plaintiffs were evaluating the rejection of the demand, sought certain additional information and were assessing next steps, and requested that the Court extend the stay for an additional 30 days, to on or around December 7, 2020. Since that time, Plaintiffs and Defendants have filed a number of joint status reports, requesting that the Court stay applicable deadlines to allow for the production of certain materials by the Board of Directors for review by Plaintiffs. The current stay ordered by the Court is set to expire on May 7, 2021. Baby Food Litigation Since the beginning of the quarter ended March 31, 2021, approximately 25 pending consumer class actions have been brought against the Company alleging that the Company’s Earth’s Best baby food products (the “Products”) contain unsafe and undisclosed levels of various naturally-occurring heavy metals, namely lead, arsenic, cadmium and mercury. These lawsuits generally allege that the Company violated various state consumer protection laws and make other state and common law warranty and unjust enrichment claims related to the alleged failure to disclose the presence of these metals and that consumers would have allegedly either not purchased the Products or would have paid less for them had the Company made adequate disclosures. These putative class actions seek to certify a nationwide class of consumers as well as various state subclasses. One of the consumer class actions (Jenna Johnson et. al. v. Beech Nut Nutrition Co., et. al.) filed in the U.S. District Court of Kansas also alleges civil RICO claims that the Company conspired with other baby food manufacturers to conceal the presence of these heavy metals in our respective products. These actions have been filed against all of the major baby food manufacturers in federal courts across the country, although the majority of cases against the Company have been filed in the U.S. District Court for the Eastern District of New York. The Company denies the allegations in these lawsuits and contends that its baby foods are safe and properly labeled. The claims raised in these lawsuits were brought in the wake of a highly-publicized report issued by the U.S. House of Representatives Subcommittee on Economic and Consumer Policy on Oversight and Reform, dated February 4, 2021 (the “House Report”), addressing the presence of heavy metals in baby foods made by certain manufacturers, including the Company. Since the publishing of the House Report, the Company has also received information requests with respect to the advertising and quality of its baby foods from certain governmental authorities, as such authorities investigate the claims made in the House Report. The Company is fully cooperating with these requests and is providing documents and other requested information. On March 8, 2021, the plaintiffs in one of the lawsuits (Albano v. Hain Celestial Group) filed a petition before the U.S. Judicial Panel on Multidistrict Litigation (“JPML”) seeking to centralize all of the consumer class action lawsuits against all of the baby food manufacturers into single multidistrict proceeding in the U.S. District Court for the Eastern District of New York. On April 13, 2021, the Company and other baby food manufacturers, as well as numerous plaintiffs in the other lawsuits, filed responses to the Albano petition. The JPML has set a hearing and oral argument on the petition for May 27, 2021. The JPML is expected to decide by early June 2021 as to whether these lawsuits will be consolidated before a single court and, if so, where. In addition to the consumer class actions discussed above, since the beginning of the quarter ended March 31, 2021, the Company has also been named in approximately six pending lawsuits in state and federal courts alleging some form of personal injury from the ingestion of the Company's Products, purportedly due to unsafe and undisclosed levels of various naturally occurring heavy metals. Six of these cases make individual claims of injury, generally related to neurological development disorders such as autism and attention deficit hyperactivity disorder. Two of the lawsuits seek relief on behalf of a class of allegedly injured persons, including damages for medical monitoring for potential injuries that may develop later. The Company denies that its Products led to any of these injuries and will defend the cases vigorously. Other In addition to the litigation described above, the Company is and may be a defendant in lawsuits from time to time in the normal course of business. While the results of litigation and claims cannot be predicted with certainty, the Company believes the reasonably possible losses of such matters, individually and in the aggregate, are not material. Additionally, the Company believes the probable final outcome of such matters will not have a material adverse effect on the Company’s consolidated results of operations, financial position, cash flows or liquidity.

CONSOLIDATED STATEMENT OF OPERATIONS (UNAUDITED) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Mar. 31, 2021	Mar. 31, 2020
Income Statement [Abstract]
Net sales	$ 492,604	$ 553,297	$ 1,519,649	$ 1,542,157
Cost of sales	362,698	420,902	1,140,614	1,206,324
Gross profit	129,906	132,395	379,035	335,833
Selling, general and administrative expenses	74,223	85,447	236,995	245,205
Amortization of acquired intangible assets	2,145	3,174	6,771	9,446
Productivity and transformation costs	4,553	11,514	12,371	37,949
Proceeds from insurance claim	(592)	(400)	(592)	(2,962)
Long-lived asset and intangibles impairment	0	13,525	57,676	15,414
Operating income	49,577	19,135	65,814	30,781
Interest and other financing expense, net	2,030	4,037	6,820	15,068
Other expense (income), net	1,566	(260)	(852)	2,312
Income from continuing operations before income taxes and equity in net (income) loss of equity-method investees	45,981	15,358	59,846	13,401
Provision (benefit) for income taxes	11,797	(10,242)	33,197	(9,753)
Equity in net (income) loss of equity-method investees	(70)	564	1,025	1,219
Net income from continuing operations	34,254	25,036	25,624	21,935
Net (loss) income from discontinued operations, net of tax	0	(697)	11,255	(105,581)
Net income (loss)	$ 34,254	$ 24,339	$ 36,879	$ (83,646)
Net income (loss) per common share:
Basic net income (loss) per common share from continuing operations (USD per share)	$ 0.34	$ 0.24	$ 0.25	$ 0.21
Basic net (loss) income per common share from discontinued operations (USD per share)	0	(0.01)	0.11	(1.01)
Basic net income (loss) per common share (USD per share)	0.34	0.23	0.36	(0.80)
Diluted net income (loss) per common share from continuing operations (USD per share)	0.34	0.24	0.25	0.21
Diluted net (loss) income per common share from discontinued operations (USD per share)	0	(0.01)	0.11	(1.01)
Diluted income (loss) per common share (USD per share)	$ 0.34	$ 0.23	$ 0.36	$ (0.80)
Shares used in the calculation of net income (loss) per common share:
Basic (shares)	99,831	104,032	100,502	104,192
Diluted (shares)	101,596	104,337	101,385	104,489

INCOME TAXES (Details) - USD ($)	3 Months Ended		9 Months Ended
INCOME TAXES (Details) - USD ($)	Mar. 31, 2021	Mar. 31, 2020	Mar. 31, 2021	Mar. 31, 2020
Income Tax [Line Items]
Effective income tax rate reconciliation (as a percent)	25.70%	(66.70%)	55.50%	(72.80%)
Income tax refund, CARES Act			$ 53,817,000
Interest on refund received, CARES Act			1,317,000
Tax expense (benefit) from tax gain on sale		$ (1,624,000)		$ 11,848,000
Tilda \| Disposed of by Sale
Income Tax [Line Items]
Tax expense (benefit) from tax gain on sale		(750,000)		14,500,000
(Benefit) provision for income taxes	$ 0	$ (965,000)	$ (11,320,000)	$ 12,900,000

- Definition

Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 3B
-URI http://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 20
-Section 45
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=109222160&loc=d3e1012-107759

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 3A
-URI http://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I.7)
-URI http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5C
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319

+ Details

GOODWILL AND OTHER INTANGIBLE ASSETS (Changes In Carrying Amount Of Goodwill) (Details) $ in Thousands	9 Months Ended
	Mar. 31, 2021 USD ($)
Goodwill
Goodwill	$ 861,958
Reclassification of goodwill to assets held for sale	(14,362)
Translation and other adjustments, net	30,127
Goodwill	877,723
Accumulated impairment losses	134,277
North America
Goodwill
Goodwill	606,055
Reclassification of goodwill to assets held for sale	0
Translation and other adjustments, net	2,642
Goodwill	608,697
International
Goodwill
Goodwill	255,903
Reclassification of goodwill to assets held for sale	(14,362)
Translation and other adjustments, net	27,484
Goodwill	269,025
United Kingdom
Goodwill
Accumulated impairment losses	97,358
Europe
Goodwill
Accumulated impairment losses	29,219
Cultivate \| Operating Segments
Goodwill
Accumulated impairment losses	$ 7,700

DERIVATIVES AND HEDGING ACTIVITIES (Balance Sheet Location) (Details) - USD ($) $ in Thousands	Mar. 31, 2021	Jun. 30, 2020
Derivatives, Fair Value [Line Items]
Derivative asset, fair value		$ 1,014
Derivative liability, fair value		6,405
Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Derivative asset, fair value	$ 682	821
Derivative liability, fair value	10,831	6,331
Prepaid expenses and other current assets \| Interest Rate Swap \| Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Derivative asset, fair value	9	0
Prepaid expenses and other current assets \| Cross-currency swap \| Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Derivative asset, fair value	673	746
Prepaid expenses and other current assets \| Foreign currency forward contracts \| Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Derivative asset, fair value		75
Prepaid expenses and other current assets \| Foreign currency forward contracts \| Not Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Derivative asset, fair value		193
Accrued expenses and other current liabilities / Other noncurrent liabilities \| Interest Rate Swap \| Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Derivative liability, fair value	313	856
Other noncurrent liabilities \| Cross-currency swap \| Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Derivative liability, fair value	$ 10,518	5,475
Other noncurrent liabilities \| Foreign currency forward contracts \| Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Derivative liability, fair value		0
Accrued expenses and other current liabilities \| Foreign currency forward contracts \| Not Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Derivative liability, fair value		$ 74

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (UNAUDITED) (Parenthetical) - $ / shares	Mar. 31, 2021	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019
Statement of Stockholders' Equity [Abstract]
Common stock, par value (USD per share)	$ 0.01	$ 0.01	$ 0.01	$ 0.01	$ 0.01	$ 0.01	$ 0.01	$ 0.01

DISPOSITIONS (Statements of Operations Tilda) (Details) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Mar. 31, 2021	Mar. 31, 2020
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Net (loss) income from discontinued operations, net of tax	$ 0	$ (697,000)	$ 11,255,000	$ (105,581,000)
Tax expense (benefit) from tax gain on sale		(1,624,000)		11,848,000
Foreign currency translation adjustments
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Amounts reclassified into income	(14,725,000)	0	(15,906,000)	(95,120,000)
Tilda \| Disposed of by Sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Net sales	0	0	0	30,399,000
Cost of sales	0	0	0	26,648,000
Gross profit	0	0	0	3,751,000
Selling, general and administrative expense	0	0	0	5,185,000
Other expense	0	0	75,000	1,172,000
Interest expense	0	0	0	2,432,000
Translation loss	0	0	0	95,120,000
Gain on sale of discontinued operations	0	540,000	0	(9,630,000)
Net loss from discontinued operations before income taxes	0	(540,000)	(75,000)	(90,528,000)
(Benefit) provision for income taxes	0	(965,000)	(11,320,000)	12,900,000
Net (loss) income from discontinued operations, net of tax	0	425,000	11,245,000	(103,428,000)
Tax expense (benefit) from tax gain on sale		(750,000)		14,500,000
Hain Pure Protein \| Disposed of by Sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Net sales	0	0	0	0
Cost of sales	0	0	0	0
Gross profit	0	0	0	0
Selling, general and administrative expense	0	0	0	0
Gain on sale of discontinued operations	0	1,781,000	0	3,205,000
Net loss from discontinued operations before income taxes	0	(1,781,000)	10,000	(3,205,000)
(Benefit) provision for income taxes	0	(659,000)	0	(1,052,000)
Net (loss) income from discontinued operations, net of tax	$ 0	$ (1,122,000)	$ 10,000	$ (2,153,000)

SEGMENT INFORMATION (Tables)

9 Months Ended

Mar. 31, 2021

Segment Reporting [Abstract]

Schedule of Segment Reporting Information

The following tables set forth financial information about each of the Company’s reportable segments. Transactions between reportable segments were insignificant for all periods presented.


	Three Months Ended March 31,				Nine Months Ended March 31,
	2021		2020		2021		2020
Net Sales:
North America	$	287,500	$	320,440	$	850,780	$	872,834
International	205,104		232,857		668,869		669,323

	$	492,604	$	553,297	$	1,519,649	$	1,542,157

Operating Income (Loss):
North America	$	39,492	$	28,873	$	105,188	$	64,067
International	26,774		18,660		8,144		40,666
	66,266		47,533		113,332		104,733
Corporate and Other (a)	(16,689)		(28,398)		(47,518)		(73,952)
	$	49,577	$	19,135	$	65,814	$	30,781

The Company's net sales by product category are as follows:


	Three Months Ended March 31,				Nine Months Ended March 31,
	2021		2020		2021		2020
Grocery	$	322,107	$	373,723	$	1,030,544	$	1,081,497

Snacks	79,768		79,252		235,641		227,925
Personal Care	50,446		66,950		144,057		138,880
Tea	40,283		33,372		109,407		93,855
Total	$	492,604	$	553,297	$	1,519,649	$	1,542,157

Net Sales Geographic Area

The Company’s net sales by geographic region, which are generally based on the location of the Company’s subsidiaries, were as follows:


	Three Months Ended March 31,				Nine Months Ended March 31,
	2021		2020		2021		2020
United States	$	251,887	$	279,534	$	735,947	$	758,759
United Kingdom	139,094		169,024		475,739		501,619
All Other	101,623		104,739		307,963		281,779
Total	$	492,604	$	553,297	$	1,519,649	$	1,542,157

Schedule of Long-lived Assets

The Company’s long-lived assets, which primarily represent net property, plant and equipment, operating lease right-of-use assets and noncurrent other assets by geographic area were as follows:


	March 31, 2021		June 30, 2020
United States	$	165,516	$	146,633
United Kingdom	148,929		149,943
All Other	109,290		105,303
Total	$	423,735	$	401,879

LEASES (Supplemental Balance Sheet Information) (Details) - USD ($) $ in Thousands	Mar. 31, 2021	Jun. 30, 2020	Mar. 31, 2020
Leases [Abstract]
Operating lease ROU assets, net	$ 90,130	$ 88,165
Finance lease ROU assets, net	615	691
Total leased assets	90,745	88,856
Current operating lease liabilities	11,086	12,338
Current finance lease liabilities	245	308
Non-current operating lease liabilities	83,564	82,962
Non-current finance lease liabilities	376	316
Total lease liabilities	$ 95,271	$ 95,924
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]			us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]	us-gaap:DebtCurrent
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]	us-gaap:OperatingLeaseLiabilityNoncurrent
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]	us-gaap:LongTermDebtNoncurrent

SEGMENT INFORMATION (Segment Data) (Details) $ in Thousands	3 Months Ended		9 Months Ended
SEGMENT INFORMATION (Segment Data) (Details) $ in Thousands	Mar. 31, 2021 USD ($)	Mar. 31, 2020 USD ($)	Mar. 31, 2021 USD ($) segment	Mar. 31, 2020 USD ($)
Segment Reporting Information [Line Items]
Number of operating segments \| segment			5
Number of reportable segments \| segment			2
Net sales	$ 492,604	$ 553,297	$ 1,519,649	$ 1,542,157
Operating Income	49,577	19,135	65,814	30,781
Productivity and transformation costs	4,553	11,514	12,371	37,949
Long-lived asset impairment				9,539
Proceeds from insurance claims				(2,962)
North America
Segment Reporting Information [Line Items]
Long-lived asset impairment				4,007
North America \| Trademarks and Tradenames
Segment Reporting Information [Line Items]
Long-lived asset impairment		7,650
International
Segment Reporting Information [Line Items]
Long-lived asset impairment				5,532
Operating Segments
Segment Reporting Information [Line Items]
Net sales	492,604	553,297	1,519,649	1,542,157
Operating Income	66,266	47,533	113,332	104,733
Operating Segments \| North America
Segment Reporting Information [Line Items]
Net sales	287,500	320,440	850,780	872,834
Operating Income	39,492	28,873	105,188	64,067
Operating Segments \| International
Segment Reporting Information [Line Items]
Net sales	205,104	232,857	668,869	669,323
Operating Income	26,774	18,660	8,144	40,666
Corporate and Other
Segment Reporting Information [Line Items]
Operating Income	(16,689)	(28,398)	(47,518)	(73,952)
Productivity and transformation costs	$ 2,804	$ 5,572	$ 6,343	$ 26,142

DISPOSITIONS

9 Months Ended

Mar. 31, 2021

Discontinued Operations and Disposal Groups [Abstract]

DISPOSITIONS

Fruit

In August 2020, the Company's Board of Directors approved a plan to sell its prepared fresh fruit, fresh fruit drinks and fresh fruit desserts division ("Fruit"), primarily consisting of the Orchard House Foods Limited business and associated brands. This decision supported the Company's overall strategy as the Fruit business did not align, and had limited synergies, with the rest of the Company's businesses. The sale was completed on January 13, 2021 (the "Closing Date") for total cash consideration of $38,547 of which $2,056 was due as of March 31, 2021 and was subsequently collected in April 2021.

Fruit operated in the United Kingdom and was included in the Company's International reportable segment, comprising 4.9% and 8.6% of the Company's net sales during the nine months ended March 31, 2021 and 2020, respectively. The Company determined that the held for sale criteria was met and classified the assets and liabilities of the Fruit business as held for sale as of September 30 and December 31, 2020, recognizing a pre-tax non-cash loss to reduce the carrying value to its estimated fair value, less costs to sell of $56,093 during the six months ended December 31, 2020.

At the Closing Date, the assets and liabilities of the Fruit business consisted of the following:


	January 13,
	2021
ASSETS
Cash and cash equivalents	$	13,559
Accounts receivable, less allowance for doubtful accounts	14,057
Inventories	5,028
Prepaid expenses and other current assets	2,728
Property, plant and equipment, net	25,039
Goodwill	14,362
Other intangible assets, net	36,171
Operating lease right-of-use assets	5,623
Allowance for reduction of assets held for sale	(58,444)
Total assets	$	58,123
LIABILITIES
Accounts payable	$	14,428
Accrued expenses and other current liabilities	4,229
Operating lease liabilities	5,039
Deferred tax liabilities	7,298
Other liabilities	1,942
Total liabilities	$	32,936

The Company deconsolidated the net assets of the Fruit business during the three months ended March 31, 2021, recognizing a pre-tax loss on sale of $1,904.

Danival

The Company entered into a definitive stock purchase agreement on June 30, 2020 for the sale of its Danival business, a component of the International reportable segment, and the transaction closed on July 21, 2020. As of June 30, 2020, the Company determined the held for sale criteria was met, resulting in assets held for sale of $8,334 and related liabilities held for sale of $3,567 being included in the Company's Consolidated Balance Sheet as of June 30, 2020. These assets and liabilities were previously presented within Prepaid and other current assets and Accrued expenses and other liabilities, respectively, in the Form 10-K and have been reclassified to conform to current year presentation. The Company deconsolidated the net assets of the Danival business upon the closing of the sale during the quarter ended September 30, 2020.

Discontinued Operations

Sale of Tilda Business

On August 27, 2019, the Company sold the entities comprising its Tilda operating segment (the “Tilda Group Entities”) and certain other assets of the Tilda business to Ebro Foods S.A. (the "Purchaser") for an aggregate price of $342,000 in cash, subject to customary post-closing adjustments based on the balance sheets of the Tilda business. The other assets sold in the transaction consisted of raw materials, consumables, packaging, and finished and unfinished goods related to the Tilda business held by other Company entities that are not Tilda Group Entities. In January 2020, the Company and the Purchaser agreed to fully resolve all matters relating to post-closing adjustments to the sale price, resulting in a final aggregate sale price of $341,800. The Company used the proceeds from the sale to pay down the remaining outstanding borrowings under its term loan and a portion of its revolving credit facility.

The Company also entered into certain ancillary agreements with the Purchaser and certain of the Tilda Group Entities in connection with the Sale and Purchase Agreement, including a transitional services agreement (the "TSA") pursuant to which the Company and the Purchaser provided transitional services to one another, and business transfer agreements pursuant to which the applicable Tilda Group Entities transferred certain non-Tilda assets and liabilities in India and the United Arab Emirates to subsidiaries of the Company to be formed in those countries. Additionally, the Company distributed certain Tilda products in the United States, Canada and Europe through the expiration of the TSA, which expired during the second quarter of fiscal 2020.

The disposition of the Tilda operating segment represented a strategic shift that had a major impact on the Company’s operations and financial results and has been accounted for as discontinued operations.

The following table presents the major classes of Tilda’s results within “Net income (loss) from discontinued operations, net of tax” in the Consolidated Statements of Operations:


	Three Months Ended March 31,				Nine Months Ended March 31,
	2021		2020		2021		2020
Net sales	$	—	$	—	$	—	$	30,399
Cost of sales	—		—		—		26,648
Gross profit	—		—		—		3,751
Selling, general and administrative expense	—		—		—		5,185

Other expense	—		—		75		1,172
Interest expense(1)	—		—		—		2,432
Translation loss(2)	—		—		—		95,120
Gain on sale of discontinued operations	—		540		—		(9,630)
Net loss from discontinued operations before income taxes	—		(540)		(75)		(90,528)
(Benefit) provision for income taxes(3)	—		(965)		(11,320)		12,900
Net income (loss) from discontinued operations, net of tax	$	—	$	425	$	11,245	$	(103,428)

(1) Interest expense was allocated to discontinued operations based on borrowings repaid with proceeds from the sale of Tilda.

(2) At the completion of the sale of Tilda, the Company reclassified $95,120 of related cumulative translation losses from Accumulated other comprehensive loss to discontinued operations, net of tax.

There were no assets or liabilities from discontinued operations associated with Tilda as of March 31, 2021 or June 30, 2020.

Sale of Hain Pure Protein Reportable Segment

In March 2018, the Company’s Board of Directors approved a plan to sell all of the operations of the HPPC operating segment, which included the Plainville Farms and FreeBird businesses, and the EK Holdings, Inc. (“Empire Kosher” or “Empire”) operating segment, which were reported in the aggregate as the Hain Pure Protein reportable segment. Collectively, these dispositions represented a

strategic shift that had a major impact on the Company’s operations and financial results and have been accounted for as discontinued operations.

The Company is presenting the operating results and cash flows of HPPC within discontinued operations in the nine months ended March 31, 2021 and in the comparable prior year period.

Sale of Plainville Farms Business ("Plainville")

On February 15, 2019, the Company completed the sale of substantially all of the assets used primarily for Plainville (a component of HPPC), which included $25,000 in cash to the purchaser, for a nominal purchase price. In addition, the purchaser assumed the current liabilities of Plainville as of the closing date. As a condition to consummating the sale, the Company entered into a Contingent Funding and Earnout Agreement, which provided for the issuance by the Company of an irrevocable stand-by letter of credit (the “Letter of Credit”) of $10,000 which expired nineteen months after issuance, during the first quarter of fiscal 2021. The Company was entitled to receive an earnout not to exceed, in the aggregate, 120% of the maximum amount that the purchaser draws on the Letter of Credit at any point from the date of issuance through the expiration of the Letter of Credit. Earnout payments are based on a specified percentage of annual free cash flow achieved for all fiscal years ending on or prior to June 30, 2026. If a subsequent change in control of Plainville occurs prior to June 30, 2026, the purchaser will pay the Company 120% of the difference between the amount drawn on the Letter of Credit less the sum of all earnout payments made prior to such time up to the net proceeds received by the purchaser. At March 31, 2021, the Company had not recorded an asset associated with the earnout.

Sale of HPPC and Empire Kosher

On June 28, 2019, the Company completed the sale of the remainder of HPPC and EK Holdings, which included the FreeBird and Empire Kosher businesses. The purchase price, net of estimated customary adjustments based on the closing balance sheet of HPPC, was $77,714. The Company used the proceeds from the sale to pay down a portion of its outstanding borrowings under its term loan. The following table presents the major classes of Hain Pure Protein’s results within “Net loss (income) from discontinued operations, net of tax” in the Consolidated Statements of Operations:


	Three Months Ended March 31,				Nine Months Ended March 31,
	2021		2020		2021		2020
Net sales	$	—	$	—	$	—	$	—
Cost of sales	—		—		—		—
Gross profit (loss)	—		—		—		—
Selling, general and administrative expense	—		—		—		—
Asset impairments	—		—		—		—
Other income	—		—		(10)		—
Loss on sale of discontinued operations(1)	—		1,781		—		3,205
Net (loss) income from discontinued operations before income taxes	—		(1,781)		10		(3,205)
Benefit for income taxes	—		(659)		—		(1,052)
Net (loss) income from discontinued operations, net of tax	$	—	$	(1,122)	$	10	$	(2,153)

(1) Primarily relates to preliminary closing balance sheet adjustments.

There were no assets or liabilities from discontinued operations associated with HPPC at March 31, 2021 or June 30, 2020.

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	$ 36,879	$ (83,646)
Net income (loss) from discontinued operations	11,255	(105,581)
Net income from continuing operations	25,624	21,935
Adjustments to reconcile net income from continuing operations to net cash provided by operating activities from continuing operations:
Depreciation and amortization	37,768	40,069
Deferred income taxes	3,216	(9,035)
Equity in net loss of equity-method investees	1,025	1,219
Stock-based compensation, net	11,888	9,581
Long-lived asset and intangibles impairment	57,676	15,414
Other non-cash items, net	494	2,335
(Decrease) increase in cash attributable to changes in operating assets and liabilities:
Accounts receivable	(20,721)	(30,870)
Inventories	(60,304)	47,280
Other current assets	56,487	10,302
Other assets and liabilities	(952)	(1,166)
Accounts payable and accrued expenses	34,316	(42,972)
Net cash provided by operating activities from continuing operations	146,517	64,092
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of property, plant and equipment	(53,062)	(46,961)
Proceeds from sale of businesses, net and other	27,094	14,428
Net cash used in investing activities from continuing operations	(25,968)	(32,533)
CASH FLOWS FROM FINANCING ACTIVITIES
Borrowings under bank revolving credit facility	206,000	197,000
Repayments under bank revolving credit facility	(231,000)	(254,500)
Repayments under term loan	0	(206,250)
Proceeds from discontinued operations entities	0	305,247
Repayments of other debt, net	(1,917)	(1,502)
Share repurchases	(80,298)	(57,406)
Shares withheld for payment of employee payroll taxes	(3,741)	(1,506)
Net cash used in financing activities from continuing operations	(110,956)	(18,917)
Effect of exchange rate changes on cash from continuing operations	5,650	(2,110)
CASH FLOWS FROM DISCONTINUED OPERATIONS
Cash used in operating activities	0	(6,146)
Cash provided by investing activities	0	297,592
Cash used in financing activities	0	(299,418)
Effect of exchange rate changes on cash from discontinued operations	0	(537)
Net cash flows used in discontinued operations	0	(8,509)
Net increase in cash and cash equivalents	15,243	2,023
Cash and cash equivalents at beginning of period	37,771	39,526
Cash and cash equivalents at end of period	$ 53,014	$ 41,549

DERIVATIVES AND HEDGING ACTIVITIES (Details) € in Thousands	3 Months Ended
DERIVATIVES AND HEDGING ACTIVITIES (Details) € in Thousands	Jun. 30, 2021 USD ($)	Mar. 31, 2021 USD ($) instrument	Mar. 31, 2021 EUR (€) instrument
Interest Rate Swap \| Cash Flow Hedging
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Number of instruments \| instrument		4	4
Notional amount		$ 230,000,000
Cross-currency swap \| Cash Flow Hedging
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Number of instruments \| instrument		1	1
Cross-currency swap \| Cash Flow Hedging \| Short
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional amount \| €			€ 24,700
Cross-currency swap \| Cash Flow Hedging \| Long
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional amount		$ 26,775,000
Cross-currency swap \| Net Investment Hedging
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Number of instruments \| instrument		2	2
Cross-currency swap \| Net Investment Hedging \| Short
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional amount \| €			€ 76,969
Cross-currency swap \| Net Investment Hedging \| Long
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional amount		$ 83,225,000
Foreign currency forward contracts \| Not Designated as Hedging Instrument
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional amount		$ 0
Forecast \| Interest Rate Swap
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Other comprehensive income (loss), cash flow hedge, reclassification	$ (174,000)
Forecast \| Cross-currency swap
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Other comprehensive income (loss), cash flow hedge, reclassification	$ (82,000)

LEASES

9 Months Ended

Mar. 31, 2021

Leases [Abstract]

LEASES

The Company leases office space, warehouse and distribution facilities, manufacturing equipment and vehicles primarily in North America and Europe. The Company determines if an arrangement is or contains a lease at inception. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. The Company’s lease agreements generally do not contain residual value guarantees or material restrictive covenants. A limited number of lease agreements include rental payments adjusted periodically for inflation.

Some of the Company’s leases contain variable lease payments, which are expensed as incurred unless those payments are based on an index or rate. Variable lease payments based on an index or rate are initially measured using the index or rate in effect at lease commencement and included in the measurement of the lease liability; thereafter, changes to lease payments due to rate or index changes are recorded as variable lease expense in the period incurred. The Company does not have any related party leases, and sublease transactions are de minimis.

The components of lease expenses for the three and nine months ended March 31, 2021 were as follows:


	Three Months Ended				Nine Months Ended
	March 31, 2021		March 31, 2020		March 31, 2021		March 31, 2020
Operating lease expenses	$	4,129	$	4,545	$	12,290	$	14,034



Finance lease expenses	72		272		318		761
Variable lease expenses	247		633		1,204		1,873
Short-term lease expenses	458		490		1,701		1,349
Total lease expenses	$	4,906	$	5,940	$	15,513	$	18,017

Supplemental balance sheet information related to leases was as follows:


Leases	Classification	March 31, 2021		June 30, 2020
Assets
Operating lease ROU assets, net	Operating lease right-of-use assets	$	90,130	$	88,165

Finance lease ROU assets, net	Property, plant and equipment, net	615		691

Total leased assets		$	90,745	$	88,856

Liabilities
Current
Operating	Accrued expenses and other current liabilities	$	11,086	$	12,338

Finance	Current portion of long-term debt	245		308

Non-current
Operating	Operating lease liabilities, noncurrent portion	83,564		82,962
Finance	Long-term debt, less current portion	376		316
Total lease liabilities		$	95,271	$	95,924

Additional information related to leases is as follows:


	Nine Months Ended
	March 31, 2021			March 31, 2020
Supplemental cash flow information
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	12,954		$	12,856
Operating cash flows from finance leases	$	13		$	18
Financing cash flows from finance leases	$	285		$	372
ROU assets obtained in exchange for lease obligations (a):
Operating leases	$	18,349		$	94,389
Finance leases	$	671		$	1,092
Weighted average remaining lease term:
Operating leases	10.0 years			8.4 years
Finance leases	4.1 years			2.3 years
Weighted average discount rate:
Operating leases	3.2		%	2.7		%
Finance leases	3.9		%	2.9		%

Maturities of lease liabilities as of March 31, 2021 were as follows:


Fiscal Year	Operating leases		Finance leases		Total
2021 (remainder of year)	$	2,665	$	71	$	2,736
2022	14,358		246		14,604
2023	13,596		133		13,729
2024	11,878		51		11,929
2025	10,663		51		10,714
Thereafter	60,084		127		60,211
Total lease payments	113,244		679		113,923
Less: Imputed interest	18,594		58		18,652
Total lease liabilities	$	94,650	$	621	$	95,271

Maturities of lease liabilities as of June 30, 2020 were as follows:


Fiscal Year	Operating leases		Finance leases		Total
2021	$	14,781	$	308	$	15,089
2022	13,798		205		14,003
2023	12,833		95		12,928
2024	10,941		18		10,959
2025	9,521		6		9,527
Thereafter	51,545		—		51,545
Total lease payments	113,419		632		114,051
Less: Imputed interest	18,119		8		18,127
Total lease liabilities	$	95,300	$	624	$	95,924

LEASES

The components of lease expenses for the three and nine months ended March 31, 2021 were as follows:


	Three Months Ended				Nine Months Ended
	March 31, 2021		March 31, 2020		March 31, 2021		March 31, 2020
Operating lease expenses	$	4,129	$	4,545	$	12,290	$	14,034



Finance lease expenses	72		272		318		761
Variable lease expenses	247		633		1,204		1,873
Short-term lease expenses	458		490		1,701		1,349
Total lease expenses	$	4,906	$	5,940	$	15,513	$	18,017

Supplemental balance sheet information related to leases was as follows:


Leases	Classification	March 31, 2021		June 30, 2020
Assets
Operating lease ROU assets, net	Operating lease right-of-use assets	$	90,130	$	88,165

Finance lease ROU assets, net	Property, plant and equipment, net	615		691

Total leased assets		$	90,745	$	88,856

Liabilities
Current
Operating	Accrued expenses and other current liabilities	$	11,086	$	12,338

Finance	Current portion of long-term debt	245		308

Non-current
Operating	Operating lease liabilities, noncurrent portion	83,564		82,962
Finance	Long-term debt, less current portion	376		316
Total lease liabilities		$	95,271	$	95,924

Additional information related to leases is as follows:


	Nine Months Ended
	March 31, 2021			March 31, 2020
Supplemental cash flow information
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	12,954		$	12,856
Operating cash flows from finance leases	$	13		$	18
Financing cash flows from finance leases	$	285		$	372
ROU assets obtained in exchange for lease obligations (a):
Operating leases	$	18,349		$	94,389
Finance leases	$	671		$	1,092
Weighted average remaining lease term:
Operating leases	10.0 years			8.4 years
Finance leases	4.1 years			2.3 years
Weighted average discount rate:
Operating leases	3.2		%	2.7		%
Finance leases	3.9		%	2.9		%

Maturities of lease liabilities as of March 31, 2021 were as follows:


Fiscal Year	Operating leases		Finance leases		Total
2021 (remainder of year)	$	2,665	$	71	$	2,736
2022	14,358		246		14,604
2023	13,596		133		13,729
2024	11,878		51		11,929
2025	10,663		51		10,714
Thereafter	60,084		127		60,211
Total lease payments	113,244		679		113,923
Less: Imputed interest	18,594		58		18,652
Total lease liabilities	$	94,650	$	621	$	95,271

Maturities of lease liabilities as of June 30, 2020 were as follows:


Fiscal Year	Operating leases		Finance leases		Total
2021	$	14,781	$	308	$	15,089
2022	13,798		205		14,003
2023	12,833		95		12,928
2024	10,941		18		10,959
2025	9,521		6		9,527
Thereafter	51,545		—		51,545
Total lease payments	113,419		632		114,051
Less: Imputed interest	18,119		8		18,127
Total lease liabilities	$	95,300	$	624	$	95,924

BUSINESS	9 Months Ended
BUSINESS	Mar. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
BUSINESS	BUSINESS The Hain Celestial Group, Inc., a Delaware corporation (collectively, along with its subsidiaries, the “Company,” and herein referred to as “Hain Celestial,” “we,” “us” and “our”), was founded in 1993 and is headquartered in Lake Success, New York. The Company’s mission has continued to evolve since its founding, with health and wellness being the core tenet — To Create and Inspire A Healthier Way of LifeTM and be the leading marketer, manufacturer and seller of organic and natural products by anticipating and exceeding consumer expectations in providing quality, innovation, value and convenience. The Company is committed to growing sustainably while continuing to implement environmentally sound business practices and manufacturing processes. Hain Celestial sells its products through specialty and natural food distributors, supermarkets, natural food stores, mass-market and e-commerce retailers, food service channels and club, drug and convenience stores in over 75 countries worldwide. The Company manufactures, markets, distributes and sells organic and natural products under brand names, with many recognized brands in the various market categories it serves, including Celestial Seasonings®, Clarks™, Cully & Sully®, Earth’s Best®, Ella’s Kitchen®, Farmhouse Fare™, Frank Cooper’s®, GG UniqueFiber®, Gale’s®, Garden of Eatin’®, Hain Pure Foods®, Hartley’s®, Health Valley®, Imagine®, Joya®, Lima®, Linda McCartney's®™ (under license), MaraNatha®, Natumi®, New Covent Garden Soup Co.®, Robertson’s®, Sensible Portions®, Spectrum®, Sun-Pat®, Terra®, The Greek Gods®, William’s™, Yorkshire Provender® and Yves Veggie Cuisine®. The Company’s personal care products are marketed under the Alba Botanica®, Avalon Organics®, Earth’s Best®, JASON®, Live Clean®, One Step® and Queen Helene® brands. The Company continues to execute the four key pillars of its strategy: (1) simplify its portfolio; (2) strengthen its capabilities; (3) expand profit margins and cash flow; and (4) reinvigorate profitable topline growth. The Company has executed this strategy, with a focus on discontinuing uneconomic investment, realigning resources to coincide with brand importance, reducing unproductive stock-keeping units (“SKUs”) and brands and reassessing current pricing architecture. As part of this initiative, the Company reviewed its product portfolio within North America and divided it into “Get Bigger” and “Get Better” brand categories. •The Company’s “Get Bigger” brands represent its strongest brands with higher margins, which compete in categories with strong growth potential. The Company has concentrated its investment in marketing, innovation and other resources to prioritize spending for these brands, in an effort to reinvigorate profitable topline growth, optimize assortment and increase share of distribution. •The Company’s “Get Better” brands are the brands in which the Company is primarily focused on simplification and expansion of profit margin. Some of these brands have historically been low margin, non-strategic brands that added complexity with minimal benefit to the Company’s operations. In addition, as part of the Company’s overall strategy, the Company may seek to dispose of businesses and brands that are less profitable or are otherwise less of a strategic fit within its core portfolio. During fiscal 2019, for example, the Company divested its Hain Pure Protein reportable segment and its WestSoy® tofu, seitan and tempeh businesses. In fiscal 2020, the Company divested its Tilda business and its Arrowhead Mills®, SunSpire®, Europe's Best®, Casbah®, Rudi’s Gluten-Free Bakery™, Rudi’s Organic Bakery® and Fountain of Truth™ brands. In fiscal 2021, the Company divested Danival®, its U.K. fruit business, primarily consisting of the Orchard House® Foods Limited business and associated brands, and subsequent to the quarter ended March 31, 2021, the Company completed the sale of both WestSoy® and Dream®. Productivity and Transformation Costs In fiscal 2019, the Company announced an initiative that sought to identify areas of cost savings and operating efficiencies to expand profit margins and cash flow. As part of this initiative, during fiscal 2020, the Company began the integration of its United States and Canada operations in alignment with the North America reportable segment structure. In addition, during fiscal 2021, the Company initiated cost reduction programs for its international businesses in the United Kingdom and Europe. The Company will carry out additional productivity initiatives under this strategy in fiscal 2021. Productivity and transformation costs include costs such as consulting and severance costs relating to streamlining the Company’s manufacturing plants, co-packers and supply chain, eliminating served categories or brands within those categories, and product rationalization initiatives which are aimed at eliminating slow moving SKUs. Discontinued Operations On August 27, 2019, the Company and Ebro Foods S.A. entered into, and consummated the transactions contemplated by, an agreement relating to the sale and purchase of the Tilda Group Entities and certain other assets. On February 15, 2019, the Company completed the sale of substantially all of the assets used primarily for the Plainville Farms business, a component of the Company’s Hain Pure Protein Corporation (“HPPC”) operating segment. On June 28, 2019, the Company completed the sale of the remainder of HPPC and Empire Kosher which included the FreeBird and Empire Kosher businesses. These dispositions were undertaken to reduce complexity in the Company’s operations and simplify the Company’s brand portfolio, in addition to allowing additional flexibility to focus on opportunities for growth and innovation in the Company’s more profitable and faster growing core businesses. Collectively, these dispositions were reported in the aggregate as the Hain Pure Protein reportable segment. These dispositions represented strategic shifts that had a major impact on the Company’s operations and financial results, and therefore, the Company is presenting the operating results and cash flows of the Tilda operating segment and the Hain Pure Protein reportable segment within discontinued operations in the current and prior periods. See Note 4, Dispositions, for additional information.

GOODWILL AND OTHER INTANGIBLE ASSETS (Components Of Trademarks And Other Intangible Assets) (Details) - USD ($) $ in Thousands	Mar. 31, 2021	Jun. 30, 2020
Indefinite-lived Intangible Assets [Line Items]
Trademarks and tradenames	$ 280,690	$ 278,103
Other intangibles	148,422	184,854
Less: accumulated amortization	(104,321)	(116,495)
Net carrying amount	324,791	346,462
Trademarks and Tradenames
Indefinite-lived Intangible Assets [Line Items]
Accumulated impairment charge	$ 93,273	$ 93,273

TERMINATION BENEFITS RELATED TO PRODUCTIVITY AND TRANSFORMATION INITIATIVES (Tables)

9 Months Ended

Mar. 31, 2021

Restructuring and Related Activities [Abstract]

Restructuring Activity and Liability Balances

The following table displays the termination benefits and personnel realignment activities and liability balances relating to the reduction in workforce for the period ended as of March 31, 2021:


	Balance at June 30, 2020		Charges (reversals)		Amounts Paid		Foreign Currency Translation & Other Adjustments		Balance at March 31, 2021
Termination benefits and personnel realignment	$	11,541	$	3,488	$	(10,051)	$	59	$	5,037

DISPOSITIONS (Statements of Operations Hain Pure Protein) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Mar. 31, 2021	Mar. 31, 2020
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Net (loss) income from discontinued operations, net of tax	$ 0	$ (697)	$ 11,255	$ (105,581)
Disposed of by Sale \| Hain Pure Protein
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Net sales	0	0	0	0
Cost of sales	0	0	0	0
Gross profit	0	0	0	0
Selling, general and administrative expense	0	0	0	0
Asset impairments	0	0	0	0
Other income	0	0	(10)	0
Loss on sale of discontinued operations	0	1,781	0	3,205
Net (loss) income from discontinued operations before income taxes	0	(1,781)	10	(3,205)
Benefit for income taxes	0	(659)	0	(1,052)
Net (loss) income from discontinued operations, net of tax	$ 0	$ (1,122)	$ 10	$ (2,153)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($) shares in Thousands, $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Additional Paid-In Capital	Retained Earnings	Retained Earnings Cumulative Effect, Period of Adoption, Adjustment	Treasury Stock	Accumulated Other Comprehensive Income (Loss)
Beginning balance at Jun. 30, 2019	$ 1,519,319	$ (439)	$ 1,088	$ 1,158,257	$ 695,017	$ (439)	$ (110,039)	$ (225,004)
Beginning balance (shares) at Jun. 30, 2019			108,833				4,614
Increase (Decrease) in Stockholders' Equity
Net income	(107,021)				(107,021)
Other comprehensive income (loss)	56,110							56,110
Issuance of common stock pursuant to stock-based compensation plans	0		$ 1	(1)
Issuance of common stock pursuant to stock-based compensation plans (shares)			40
Shares withheld for payment of employee payroll taxes due on shares issued under stock-based compensation plans	(312)						$ (312)
Shares withheld for payment of employee payroll taxes due on shares issued under stock based compensation plans (shares)							17
Stock-based compensation expense	3,281			3,281
Ending balance at Sep. 30, 2019	1,470,938		$ 1,089	1,161,537	587,557		$ (110,351)	(168,894)
Ending balance (shares) at Sep. 30, 2019			108,873				4,631
Beginning balance at Jun. 30, 2019	1,519,319	(439)	$ 1,088	1,158,257	695,017	(439)	$ (110,039)	(225,004)
Beginning balance (shares) at Jun. 30, 2019			108,833				4,614
Increase (Decrease) in Stockholders' Equity
Net income	(83,646)
Ending balance at Mar. 31, 2020	1,439,048		$ 1,092	1,168,378	610,932		$ (168,951)	(172,403)
Ending balance (shares) at Mar. 31, 2020			109,089				7,117
Beginning balance at Jun. 30, 2019	1,519,319	(439)	$ 1,088	1,158,257	695,017	(439)	$ (110,039)	(225,004)
Beginning balance (shares) at Jun. 30, 2019			108,833				4,614
Ending balance at Jun. 30, 2020	$ 1,443,554	(310)	$ 1,092	1,171,875	614,171	(310)	$ (172,192)	(171,392)
Ending balance (shares) at Jun. 30, 2020	109,123		109,123				7,238
Increase (Decrease) in Stockholders' Equity
Accounting Standards Update	us-gaap:AccountingStandardsUpdate201613Member
Beginning balance at Sep. 30, 2019	$ 1,470,938		$ 1,089	1,161,537	587,557		$ (110,351)	(168,894)
Beginning balance (shares) at Sep. 30, 2019			108,873				4,631
Increase (Decrease) in Stockholders' Equity
Net income	(964)				(964)
Other comprehensive income (loss)	48,697							48,697
Issuance of common stock pursuant to stock-based compensation plans	0		$ 2	(2)
Issuance of common stock pursuant to stock-based compensation plans (shares)			146
Shares withheld for payment of employee payroll taxes due on shares issued under stock-based compensation plans	(671)						$ (671)
Shares withheld for payment of employee payroll taxes due on shares issued under stock based compensation plans (shares)							27
Stock-based compensation expense	3,083			3,083
Ending balance at Dec. 31, 2019	1,521,083		$ 1,091	1,164,618	586,593		$ (111,022)	(120,197)
Ending balance (shares) at Dec. 31, 2019			109,019				4,658
Increase (Decrease) in Stockholders' Equity
Net income	24,339				24,339
Other comprehensive income (loss)	(52,206)							(52,206)
Issuance of common stock pursuant to stock-based compensation plans	0		$ 1	(1)
Issuance of common stock pursuant to stock-based compensation plans (shares)			70
Shares withheld for payment of employee payroll taxes due on shares issued under stock-based compensation plans	(523)						$ (523)
Shares withheld for payment of employee payroll taxes due on shares issued under stock based compensation plans (shares)							20
Repurchases of common stock	(57,406)						$ (57,406)
Repurchases of common stock (shares)							2,439
Stock-based compensation expense	3,761			3,761
Ending balance at Mar. 31, 2020	1,439,048		$ 1,092	1,168,378	610,932		$ (168,951)	(172,403)
Ending balance (shares) at Mar. 31, 2020			109,089				7,117
Beginning balance at Jun. 30, 2020	$ 1,443,554	(310)	$ 1,092	1,171,875	614,171	(310)	$ (172,192)	(171,392)
Beginning balance (shares) at Jun. 30, 2020	109,123		109,123				7,238
Increase (Decrease) in Stockholders' Equity
Net income	$ 485				485
Other comprehensive income (loss)	31,005							31,005
Issuance of common stock pursuant to stock-based compensation plans	0		$ 1	(1)
Issuance of common stock pursuant to stock-based compensation plans (shares)			54
Shares withheld for payment of employee payroll taxes due on shares issued under stock-based compensation plans	(468)						$ (468)
Shares withheld for payment of employee payroll taxes due on shares issued under stock based compensation plans (shares)							20
Repurchases of common stock	(42,052)						$ (42,052)
Repurchases of common stock (shares)							1,281
Stock-based compensation expense	4,367			4,367
Ending balance at Sep. 30, 2020	1,436,581		$ 1,093	1,176,241	614,346		$ (214,712)	(140,387)
Ending balance (shares) at Sep. 30, 2020			109,177				8,539
Beginning balance at Jun. 30, 2020	$ 1,443,554	$ (310)	$ 1,092	1,171,875	614,171	$ (310)	$ (172,192)	(171,392)
Beginning balance (shares) at Jun. 30, 2020	109,123		109,123				7,238
Increase (Decrease) in Stockholders' Equity
Net income	$ 36,879
Ending balance at Mar. 31, 2021	$ 1,501,682		$ 1,096	1,183,759	650,740		$ (256,231)	(77,682)
Ending balance (shares) at Mar. 31, 2021	109,466		109,466				9,753
Beginning balance at Sep. 30, 2020	$ 1,436,581		$ 1,093	1,176,241	614,346		$ (214,712)	(140,387)
Beginning balance (shares) at Sep. 30, 2020			109,177				8,539
Increase (Decrease) in Stockholders' Equity
Net income	2,140				2,140
Other comprehensive income (loss)	43,044							43,044
Issuance of common stock pursuant to stock-based compensation plans	0		$ 2	(2)
Issuance of common stock pursuant to stock-based compensation plans (shares)			162
Shares withheld for payment of employee payroll taxes due on shares issued under stock-based compensation plans	(1,255)						$ (1,255)
Shares withheld for payment of employee payroll taxes due on shares issued under stock based compensation plans (shares)							38
Repurchases of common stock	(29,684)						$ (29,684)
Repurchases of common stock (shares)							923
Stock-based compensation expense	3,823			3,823
Ending balance at Dec. 31, 2020	1,454,649		$ 1,095	1,180,062	616,486		$ (245,651)	(97,343)
Ending balance (shares) at Dec. 31, 2020			109,339				9,500
Increase (Decrease) in Stockholders' Equity
Net income	34,254				34,254
Other comprehensive income (loss)	19,661							19,661
Issuance of common stock pursuant to stock-based compensation plans	0		$ 1	(1)
Issuance of common stock pursuant to stock-based compensation plans (shares)			127
Shares withheld for payment of employee payroll taxes due on shares issued under stock-based compensation plans	(2,018)						$ (2,018)
Shares withheld for payment of employee payroll taxes due on shares issued under stock based compensation plans (shares)							49
Repurchases of common stock	(8,562)						$ (8,562)
Repurchases of common stock (shares)							204
Stock-based compensation expense	3,698			3,698
Ending balance at Mar. 31, 2021	$ 1,501,682		$ 1,096	$ 1,183,759	$ 650,740		$ (256,231)	$ (77,682)
Ending balance (shares) at Mar. 31, 2021	109,466		109,466				9,753

ACCUMULATED OTHER COMPREHENSIVE LOSS (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Mar. 31, 2021	Mar. 31, 2020
Accumulated Other Comprehensive Income (Loss) [Line Items]
Total other comprehensive income (loss)	$ 19,661	$ (52,206)	$ 93,710	$ 52,601
Foreign currency translation adjustments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive income (loss) before reclassifications	1,672	(52,315)	80,491	(42,602)
Amounts reclassified into income (expense)	14,725	0	15,906	95,120
Deferred gains (losses) on cash flow hedging instruments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive income (loss) before reclassifications	1,168		(621)	0
Amounts reclassified into income (expense)	(914)	109	995	83
Deferred gains (losses) on net investment hedging instruments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive income (loss) before reclassifications	3,107	0	(2,763)	0
Amounts reclassified into income (expense)	(97)	0	(298)	0
Intra-entity foreign currency transactions
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive income (loss) before reclassifications	$ 0	$ 453	$ 0	$ 703

BASIS OF PRESENTATION (Policies)	9 Months Ended
BASIS OF PRESENTATION (Policies)	Mar. 31, 2021
Accounting Policies [Abstract]
Basis of Presentation	BASIS OF PRESENTATION The Company’s unaudited consolidated financial statements include the accounts of the Company and its wholly-owned and majority-owned subsidiaries. Intercompany accounts and transactions have been eliminated in consolidation. Investments in affiliated companies in which the Company exerts significant influence, but which it does not control, are accounted for under the equity method of accounting. As such, consolidated net loss includes the Company's equity in the current earnings or losses of such companies. The Company's unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by U.S. GAAP and should be read in conjunction with the Company's Annual Report on Form 10-K for the fiscal year ended June 30, 2020 (the “Form 10-K”). The amounts as of and for the periods ended June 30, 2020 are derived from the Company’s audited annual financial statements. The unaudited consolidated financial statements reflect all normal recurring adjustments which, in management’s opinion, are necessary for a fair presentation for interim periods. Operating results for the nine months ended March 31, 2021 are not necessarily indicative of the results that may be expected for the fiscal year ending June 30, 2021. Please refer to the Notes to the Consolidated Financial Statements as of June 30, 2020 and for the fiscal year then ended included in the Form 10-K for information not included in these condensed notes. All amounts in the unaudited consolidated financial statements, notes and tables have been rounded to the nearest thousand, except par values and per share amounts, unless otherwise indicated.
Reclassifications	Reclassifications Certain prior year amounts have been reclassified to conform with current year presentation.
Significant Accounting Policies	Significant Accounting Policies The Company's significant accounting policies are described in Note 2, Summary of Significant Accounting Policies and Practices, in the Notes to the Consolidated Financial Statements in the Form 10-K. Included herein are certain updates to those policies. Valuation of Accounts Receivable The Company maintains an allowance for expected uncollectible accounts receivable which is recorded as an offset to trade accounts receivable on the Consolidated Balance Sheets. Effective July 1, 2020, collectability of accounts receivable is assessed by applying a historical loss-rate methodology in accordance with Accounting Standards Codification ("ASC") Topic 326, Financial Instruments - Credit Losses, adjusted as necessary based on the Company's review of accounts receivable on an individual basis, specifically identifying customers with known disputes or collectability issues, and experience with trade receivable aging categories. The Company also considers market conditions and current and expected future economic conditions to inform adjustments to historical loss data. Changes to the allowance, if any, are classified as bad debt provisions in the Consolidated Statements of Operations.
Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements Not Yet Effective	Recently Adopted Accounting Pronouncements In June 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2016-13, Measurement of Credit Losses on Financial Instruments, which requires measurement and recognition of expected versus incurred credit losses for most financial assets. The ASU applies to trade and other receivables recorded on the Consolidated Balance Sheets. The Company adopted the standard on July 1, 2020 using the modified retrospective transition method, recognizing an adjustment to beginning retained earnings of $310 reflecting the cumulative impact of adoption. The adoption did not materially impact the Company's results of operations or financial position, and as a result, comparisons between periods were not materially affected by the adoption of ASU 2016-13. In January 2017, the FASB issued ASU 2017-04, Simplifying the Test for Goodwill Impairment, which removes the second step of the goodwill impairment test that requires a hypothetical purchase price allocation. A goodwill impairment will now be the amount by which a reporting unit’s carrying value exceeds its fair value, not to exceed the carrying amount of goodwill. This guidance is effective for interim and annual reporting periods beginning after December 15, 2019. The Company adopted ASU 2017-04 on July 1, 2020, and the adoption of this standard did not have an impact on the Company’s consolidated financial statements. In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement: Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement, which modifies the disclosure requirements for fair value measurement by removing, modifying or adding certain disclosures. The new guidance is effective for annual periods beginning after December 15, 2019, and for interim periods within those fiscal years. The Company adopted ASU 2018-13 on July 1, 2020, and the adoption of this standard did not have an impact on the Company’s consolidated financial statements. In August 2018, the FASB issued ASU 2018-15, Intangibles - Goodwill and Other - Internal-Use Software, Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract, which aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The amended guidance is effective for annual periods beginning after December 15, 2019, and for interim periods within those fiscal years. The Company adopted ASU 2018-15 on July 1, 2020, and the adoption of this standard did not have an impact on the Company’s consolidated financial statements. Recently Issued Accounting Pronouncements Not Yet Effective In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which simplifies various aspects related to accounting for income taxes and eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating taxes during the quarters and the recognition of deferred tax liabilities for outside basis differences. The new guidance is effective for annual periods beginning after December 15, 2021, and for interim periods within those fiscal years. The Company is currently assessing the impact that this standard will have on its consolidated financial statements. In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides temporary optional expedients and exceptions for applying generally accepted accounting principles to contracts, hedging relationships and other transactions affected by reference rate reform. ASU 2020-04 is currently effective and upon adoption may be applied prospectively to contract modifications made on or before December 31, 2022. In January 2021, the FASB issued ASU 2021-01, Reference Rate Reform (Topic 848): Scope, which clarifies certain provisions in Topic 848, if elected by an entity, to apply to derivative instruments that use an interest rate for margining, discounting, or contract price alignment that is modified as a result of reference rate reform. The Company is currently assessing the impact that these standards will have on its consolidated financial statements. In October 2020, the FASB issued ASU 2020-10, Codification Improvements - Disclosures. This ASU improves consistency by amending the codification to include all disclosure guidance in the appropriate disclosure sections and clarifies application of various provisions in the codification by amending and adding new headings, cross referencing to other guidance, and refining or correcting terminology. This ASU is effective for fiscal years beginning after December 15, 2020. The Company is currently assessing the impact that this standard will have on its consolidated financial statements.

TERMINATION BENEFITS RELATED TO PRODUCTIVITY AND TRANSFORMATION INITIATIVES

9 Months Ended

Mar. 31, 2021

Restructuring and Related Activities [Abstract]

TERMINATION BENEFITS RELATED TO PRODUCTIVITY AND TRANSFORMATION INITIATIVES

As a part of the ongoing productivity and transformation initiatives related to the Company’s strategic objective to expand profit margins and cash flow, the Company initiated a reduction in workforce at targeted locations in the United States as well as at certain locations internationally. The reduction in workforce associated with these initiatives are expected to result in charges throughout fiscal 2021.

The following table displays the termination benefits and personnel realignment activities and liability balances relating to the reduction in workforce for the period ended as of March 31, 2021:


	Balance at June 30, 2020		Charges (reversals)		Amounts Paid		Foreign Currency Translation & Other Adjustments		Balance at March 31, 2021
Termination benefits and personnel realignment	$	11,541	$	3,488	$	(10,051)	$	59	$	5,037

The liability balance as of March 31, 2021 and June 30, 2020 is included within Accrued expenses and other current liabilities on the Company’s Consolidated Balance Sheets.

GOODWILL AND OTHER INTANGIBLE ASSETS (Amortization Expense) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Mar. 31, 2021	Mar. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization of acquired intangibles	$ 2,145	$ 3,174	$ 6,771	$ 9,446

DEBT AND BORROWINGS (Components Of Debt) (Details) - USD ($) $ in Thousands	Mar. 31, 2021	Jun. 30, 2020
Line of Credit Facility [Line Items]
Other borrowings	$ 1,239	$ 2,774
Long-term debt	256,239	282,774
Short-term borrowings and current portion of long-term debt	699	1,656
Long-term debt, less current portion	255,540	281,118
Amended Credit Agreement \| Unsecured revolving credit facility
Line of Credit Facility [Line Items]
Revolving credit facility	$ 255,000	$ 280,000

- Definition

The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.

+ References + Details

EARNINGS (LOSS) PER SHARE (Computation Of Basic And Diluted Earnings Per Share) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended						9 Months Ended
	Mar. 31, 2021	Dec. 31, 2020	Sep. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Sep. 30, 2019	Mar. 31, 2021	Mar. 31, 2020
Earnings Per Share [Abstract]
Net income from continuing operations	$ 34,254			$ 25,036			$ 25,624	$ 21,935
Net (loss) income from discontinued operations, net of tax	0			(697)			11,255	(105,581)
Net income (loss)	$ 34,254	$ 2,140	$ 485	$ 24,339	$ (964)	$ (107,021)	$ 36,879	$ (83,646)
Denominator:
Basic weighted average shares outstanding (shares)	99,831			104,032			100,502	104,192
Effect of dilutive stock options, unvested restricted stock and unvested restricted share units (shares)	1,765			305			883	297
Diluted weighted average shares outstanding (shares)	101,596			104,337			101,385	104,489
Basic net income (loss) per common share:
Basic net income (loss) per common share from continuing operations (USD per share)	$ 0.34			$ 0.24			$ 0.25	$ 0.21
Basic net (loss) income per common share from discontinued operations (USD per share)	0			(0.01)			0.11	(1.01)
Basic net income (loss) per common share (USD per share)	0.34			0.23			0.36	(0.80)
Diluted net income (loss) per common share:
Diluted net income (loss) per common share from continuing operations (USD per share)	0.34			0.24			0.25	0.21
Diluted net (loss) income per common share from discontinued operations (USD per share)	0			(0.01)			0.11	(1.01)
Diluted income (loss) per common share (USD per share)	$ 0.34			$ 0.23			$ 0.36	$ (0.80)

TERMINATION BENEFITS RELATED TO PRODUCTIVITY AND TRANSFORMATION INITIATIVES (Details) - Termination benefits and personnel realignment - Productivity and Transformation Costs Initiative $ in Thousands	9 Months Ended
	Mar. 31, 2021 USD ($)
Restructuring Reserve [Roll Forward]
Restructuring reserve, beginning balance	$ 11,541
Charges (reversals)	3,488
Amounts Paid	(10,051)
Foreign Currency Translation & Other Adjustments	59
Restructuring reserve, ending balance	$ 5,037

INVESTMENTS (Details) - USD ($) $ in Thousands	Mar. 31, 2021	Jun. 30, 2020
Chop't
Schedule of Equity Method Investments [Line Items]
Equity method investments	$ 11,098	$ 12,793
Yeo Hiap Seng Limited
Schedule of Equity Method Investments [Line Items]
Ownership percentage, less than	1.00%
HHO, Hain Future, and Yeo Hiap Seng Limited
Schedule of Equity Method Investments [Line Items]
Equity method investments	$ 6,244	$ 4,646

EARNINGS (LOSS) PER SHARE (Narrative) (Details) - USD ($) $ / shares in Units, shares in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Mar. 31, 2021	Mar. 31, 2020	Jun. 21, 2017
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Authorized amount					$ 250,000,000
Number of shares repurchased (in shares)	204		2,408
Shares repurchased (shares)	$ 8,562,000		$ 80,255,000
Average cost (USD per share)	$ 41.86		$ 33.33
Remaining authorized repurchase amount	$ 109,495,000		$ 109,495,000
Restricted Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (shares)	4	512	182	450
Stock Based Awards
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (shares)	23	2,616	957	2,685

FINANCIAL INSTRUMENTS MEASURED AT FAIR VALUE (Assets And Liabilities Measured At Fair Value On A Recurring Basis) (Details) - USD ($) $ in Thousands	Mar. 31, 2021	Jun. 30, 2020
Assets:
Cash equivalents		$ 7
Derivative financial instruments	$ 682	1,014
Equity investment	618	562
Assets total	1,300	1,583
Liabilities:
Derivative financial instruments	10,831	6,405
Liabilities total	10,831	6,405
Quoted prices in active markets (Level 1)
Assets:
Cash equivalents		7
Derivative financial instruments	0	0
Equity investment	618	562
Assets total	618	569
Liabilities:
Derivative financial instruments	0	0
Liabilities total	0	0
Significant other observable inputs (Level 2)
Assets:
Cash equivalents		0
Derivative financial instruments	682	1,014
Equity investment	0	0
Assets total	682	1,014
Liabilities:
Derivative financial instruments	10,831	6,405
Liabilities total	10,831	6,405
Significant unobservable inputs (Level 3)
Assets:
Cash equivalents		0
Derivative financial instruments	0	0
Equity investment	0	0
Assets total	0	0
Liabilities:
Derivative financial instruments	0	0
Liabilities total	$ 0	$ 0

INCOME TAXES	9 Months Ended
INCOME TAXES	Mar. 31, 2021
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES In general, the Company uses an estimated annual effective tax rate, which is based on expected annual income and statutory tax rates in the various jurisdictions in which the Company operates, to determine its quarterly provision for income taxes. Certain significant or unusual items are separately recognized in the quarter in which they occur and can be a source of variability on the effective tax rates from quarter to quarter. The Company’s effective tax rate may change from period-to-period based on recurring and non-recurring factors including the geographical mix of earnings, enacted tax legislation, state and local income taxes and tax audit settlements. The effective income tax rate from continuing operations was an expense of 25.7% and a benefit of 66.7% for the three months ended March 31, 2021 and 2020, respectively. The effective income tax rate from continuing operations was an expense of 55.5% and a benefit of 72.8% for the nine months ended March 31, 2021 and 2020, respectively. The effective income tax rates from continuing operations for the nine months ended March 31, 2021 were impacted by various discrete items including the tax impact of the Fruit impairment and disposal, the enacted change in the United Kingdom's corporate income tax rate to 19% and a legal entity reorganization completed during the quarter ended September 30, 2020. In addition, the effective income tax rates from continuing operations for the three and nine months ended March 31, 2021 and 2020 were impacted by provisions in the Tax Cuts and Jobs Act (the "Tax Act"), primarily related to Global Intangible Low Taxed Income ("GILTI") and limitations on the deductibility of executive compensation. The effective income tax rates in each period were also impacted by the geographical mix of earnings and state valuation allowance. Through the nine months ended March 31, 2021, the Company received $53,817 including $1,317 of interest from the Coronavirus Aid, Relief, and Economic Security Act (the "CARES Act") tax loss carryback refund claims. There were no discontinued operations for the three months ended March 31, 2021 and an income tax benefit from discontinued operations of $11,320 for the nine months ended March 31, 2021. The income tax from discontinued operations was a benefit of $1,624 and expense of $11,848 for the three and nine months ended March 31, 2020, respectively. The benefit for income tax for the nine months ended March 31, 2021 was impacted by a legal entity reorganization. The expense for income taxes for the nine months ended March 31, 2020 was impacted by $14,500 of tax related to the tax gain on the sale of the Tilda entities.

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References + Details

PROPERTY, PLANT AND EQUIPMENT, NET (Tables)

9 Months Ended

Mar. 31, 2021

Property, Plant and Equipment [Abstract]

Schedule of Property, Plant and Equipment, Net

Property, plant and equipment, net consisted of the following:


	March 31, 2021		June 30, 2020
Land	$	14,561	$	13,866
Buildings and improvements	73,240		74,325
Machinery and equipment	317,270		288,466
Computer hardware and software	61,661		60,391
Furniture and fixtures	23,272		20,044
Leasehold improvements	39,009		40,876
Construction in progress	34,980		16,489
	563,993		514,457
Less: accumulated depreciation and amortization	252,651		225,201
	$	311,342	$	289,256

ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)

9 Months Ended

Mar. 31, 2021

Equity [Abstract]

Schedule of Accumulated Other Comprehensive (Loss) Income

The following table presents the changes in accumulated other comprehensive loss ("AOCL"):


	Three Months Ended March 31,				Nine Months Ended March 31,
	2021		2020		2021		2020
Foreign currency translation adjustments:
Other comprehensive income (loss) before reclassifications (1)	$	1,672	$	(52,315)	$	80,491	$	(42,602)
Amounts reclassified into income (2)	14,725		—		15,906		95,120
Deferred gains (losses) on cash flow hedging instruments:

Amount of gain (loss) gain recognized in AOCL on derivatives (3)	1,168				(621)		—
Amount of (loss) gain reclassified from AOCL into (expense) income (3)	(914)		109		995		83
Deferred gains (losses) on net investment hedging instruments:

Amount of gain (loss) recognized in AOCL on derivatives (3)	3,107		—		(2,763)		—
Amount of loss reclassified from AOCL into expense (3)	(97)		—		(298)		—
Net change in AOCL	$	19,661	$	(52,206)	$	93,710	$	52,601